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 Cytochrome P450 (P450 or CYP) catalysis involves the oxygenation of organic 
compounds via a series of catalytic intermediates, namely, the ferric-peroxo, ferric-
hydroperoxo, Compound I (Cpd I), and Fe
III
(H2O2) intermediates. The general 
consensus is that the Cpd I intermediate is the most reactive species in the reaction cycle, 
especially when the reaction involves hydrocarbon hydroxylation. Other than Cpd I, there 
is a multitude of evidence, both experimental as well as theoretical, supporting the 
involvement of other intermediates in various types of oxidation reactions. In part I of 
this work, the multiple oxidant hypothesis of P450 catalysis has been probed using P450-
CAM from Pseudomonas putida, a prototypical P450 enzyme. P450-CAM is a versatile 
catalyst that has been shown to catalyze many typical P450 reactions in camphor analog 
substrates. The active site threonine-252 to alanine (T252A) mutant of P450-CAM on 
reaction with camphor yields H2O2 and minimal oxidized camphor, presumably because 
it makes very little Compound I while still generating the ferric-peroxo and ferric-
hydroperoxo species. This makes T252A P450-CAM an ideal catalyst to probe the 
multiple oxidant hypothesis. Using heteroatom-containing substrates, including camphor 
analog substrates modified at the fifth position, we have compared the quantitative 
product formation between WT and T252A P450-CAM to gain an insight in the multiple 
oxidant hypothesis. 
 Magnetic circular dichroism  (MCD) spectroscopy also known as the Faraday 
effect, is an excellent fingerprinting tool of various heme systems.  
vii 
 
It can be used for assigning axial ligand identity, coordination numbers as well as spin 
state determination of the heme iron, which can lead to important information about their 
structures and functions. In part two of this work, we present results from the application 
of MCD spectroscopy in the axial ligand(s) identification analysis of three novel heme 
proteins, sGAF2, Z-ISO and Phu_R, and in the characterization of the dioxygen complex 
of an engineered P450BM3 protein. 
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Cytochrome P450 (P450 or CYP) catalysis involves the oxygenation of organic 
compounds via a series of catalytic intermediates, namely, the ferric-peroxo, ferric-
hydroperoxo, Compound I (Cpd I) and Fe
III
(H2O2) intermediates. Now that the 
structures of P450 enzymes have been well established, a major focus of current research 
in the P450 area has been unraveling the intimate details and activities of these reactive 
intermediates. The general consensus is that the Cpd I intermediate is the most reactive 
species in the reaction cycle, especially when the reaction involves hydrocarbon 
hydroxylation. Cpd I has recently been characterized experimentally. Other than Cpd I, 
there is a multitude of evidence, both experimental as well as theoretical, supporting the 
involvement of other intermediates in various types of oxidation reactions. The 
involvement of these multiple oxidants has been experimentally demonstrated using P450 
active-site mutants in epoxidation, heteroatom oxidation and dealkylation reactions. In 
this chapter, we will review the P450 reaction cycle and each of the reactive 
intermediates to discuss their role in oxidation reactions. 
1.1  Introduction 
Cytochrome P450 enzymes are heme-thiolate ligated monooxygenases that are 
ubiquitous in the biological kingdom and catalyze a variety of oxidation reactions 
covering a wide range of substrates.
1, 2
 Hemeproteins are classified as P450s when their 
Fe
II
CO complex has a maximum Soret absorbance at 450 nm.
3
 P450s were discovered 
five decades ago because of their important role in xenobiotic clearance from the human 
body, but the interesting nature of their chemistry has attracted attention from chemists, 




activation is central to life as spin forbiddance makes ground-state triplet molecular 
oxygen by itself inert toward organic molecules.
4
 Living beings therefore use enzyme 
systems for oxygen activation to perform biologically important reduction-oxidation 
(redox) reactions. P450s are one of the metal-containing oxygenases that utilize 
molecular oxygen to stereo- and regioselectively oxygenate substrates under 
physiological conditions. While P450s are capable of diverse reactions, they are in fact 
mostly known for their ability to catalyze the oxidation of inert substrate CH bonds 
under physiological conditions. To put into perspective, the bond strength of a typical 




 Present understanding of the P450 
catalytic mechanism has been developed over the course of the last four decades by 
advances in genomics, molecular biology and spectroscopy.
6
 Comparison with analogous 
heme oxygen activation systems has also greatly contributed to our current understanding 
of its mechanism. Knowledge of the P450 intermediates is now being used for 
development of efficient inorganic catalysts for laboratory and commercial use.
7
 




Oxidation of substrates by P450 can be summarized by the following equation: 
                 
                      
The catalytic mechanism of P450s occurs in a cyclic fashion involving systematic 
generation of intermediates, some of which are transient.
9
 Electrons for this oxidation 
reaction are provided by NAD(P)H and are shuttled to the P450 active site with the aid of 
reductase enzymes. Protons are donated by water molecules in the active site. Based on 






 Type I P450s are mainly the mammalian mitochondrial and bacterial 
P450s, which utilize a flavoprotein to transfer electrons to P450s via an intervening iron-
sulfur cluster protein (Fe2S2). Type II P450s are the mammalian xenobiotic-metabolizing 
enzymes that receive electrons via FAD- and FMN-containing reductases. There are 
certain exceptions such as P450BM3 in which the heme and FMN/FAD-containing 






Scheme 1.1 Electron transfer chains in class I and class II of P450 enzymes, see Ref. 10. 
1.2 The P450 Catalytic Cycle  
P450-CAM (CYP101) is a bacterial P450 enzyme from Pseudomonas putida that 
converts 1R-(+)-camphor to 5-exo-hydroxycamphor. This enzyme is soluble and 
therefore easy to purify and was the first P450 whose crystal structure was solved.
13
 
Since then, its structure has been extensively studied and it has served as a prototype for 
structure-function studies of the entire P450 family. The reaction cycle for P450-CAM 
also holds true for the entire P450 family. The putative catalytic mechanism of P450s in 
which the substrate RH is oxidized to R-OH in a series of steps is shown in Scheme. 1.2. 
The catalytic cycle begins with the reversible substrate binding to the water-coordinated 












causes displacement of water as the sixth ligand to the heme with formation of the high-
spin (S=5/2) pentacoordinate enzyme-substrate adduct (Scheme. 1.2, 2). This causes the 
midpoint redox potential of the heme to shift to a more positive value (from 330 mV to 
173 mV).
14
 The sharp shift in the reduction potential resulting from substrate binding 
enables electrons to flow from NAD(P)H to the P450 enzyme via an associated reductase. 
The first electron generates the reduced ferrous-substrate adduct (Scheme. 1.2, 3). 
Subsequent binding of dioxygen generates the oxyferrous complex or a resonance-






 superoxide radical anion 
coordinated to the ferric heme center with an unpaired electron on the terminal oxygen 
atom (Scheme. 1.2, 4).
15
 The second electron from NAD(P)H then reduces the oxyferrous 




 (Scheme. 1.2, 5) ferric-peroxo intermediate. This is 
also the rate-limiting step. Protonation of this intermediate leads to the Fe
+3
-OOH 
(Scheme. 1.2, 6) ferric-hydroperoxo intermediate, also known as Compound 0 (Cpd 0). A 
second protonation of this intermediate leads to OO bond heterolysis forming the highly 
transient and reactive porphyrin π radical cation ferryl complex (Scheme. 1.2, 7) known 
as Cpd I. Cpd I derives its name from the analogous high-valent Cpd I species of heme 
peroxidases.
16, 17
 According to the now well-accepted mechanism for hydrocarbon 
hydroxylation, Cpd I abstracts a H atom from the substrate resulting in a ferryl hydroxyl 
intermediate (Scheme. 1.2, 8) known as protonated Compound II (Cpd II) and a substrate 
radical. In what is known as the oxygen rebound, the hydroxyl moiety on the iron 
combines with the substrate radical to give the hydroxylated product, while the enzyme 






Scheme 1.2 Reactive intermediates and shunt pathways in the catalytic cycle of P450 
enzymes. 
In addition to the normal catalytic pathway, there are three uncoupling reactions 
within the cycle that lead back to the enzyme-substrate adduct without any product 
formation. The first is the auto-oxidation of the oxyferrous enzyme with simultaneous 
generation of a superoxide anion (Scheme. 1.2, I). In the second shunt pathway, the 
hydroperoxo anion dissociates from the ferric-hydroperoxo intermediate (Scheme. 1.2, 

























































































protonation at the distal oxygen generates the Fe
+3
-H2O2 intermediate (Scheme. 1.2, 9) 
followed by dissociation of hydrogen peroxide without substrate turnover. This pathway 
is often seen in the active-site alcohol-alanine mutant.
18
 In the oxidase shunt (Scheme. 
1.2, III), the ferryl intermediate is reduced to water in lieu of substrate oxidation. In an 
alternative pathway to the normal reaction cycle, the enzyme can be turned over without 
the nucleotide-reducing equivalents via the peroxide shunt (Scheme. 1.2, IV). Cpd I can 




1.3 Nature of the P450 Active Site 
There are over 20,000 known CYP genes 
(http://drnelson.uthsc.edu/CytochromeP450.html). P450s share their catalytic capabilities 
with other heme-containing enzymes, catalases, peroxidases and oxygenases, but they are 
all very different structurally. The architecture of the active site in P450s plays an 
important role in the sequential generation of intermediates in the catalytic cycle. For a 
complete understanding of P450 monooxygenation chemistry, the majority of research 
has focused on the factors influencing electron delivery and dioxygen binding to the 
heme iron, proton addition to the bound dioxygen in the distal pocket of the heme and 
cleavage of the OO bond. Residues most important for oxygen activation are the heme 
proximal cysteine ligand (Cys357 in P450CAM) and the acid-alcohol pair in the distal 
pocket of the heme (Thr252-Asp251 in P450CAM). These amino acids are conserved in 
the active site of almost all P450s. Since the active site is hydrophobic, a chain of water 




each other and to the alcohol residue in the active site (Thr252 in P450CAM).
22
 The 
active site of camphor-bound oxy-P450-CAM is shown in Figure. 1.1. 
In this landmark work, Schlichting and coworkers structurally characterized the 
oxyferrous complex of P450CAM using cryocrystallography. 
9
 Important residues 
involved in oxygen activation were Cys357, Asp251, Thr252 as well as the bound 
camphor substrate and are shown in Fig. 3. The hydroxyl group of Tyr96 H-bonds to the 
keto group of camphor to orient the site of oxygenation above the heme. The water 
molecules Wat901 and Wat902 seen in the active site are implicated as the source of 
protons required for formation of the active Fe
IV
=O species. Accordingly, the Thr252 H-
bonds to Wat901, which serves as the H-bond donor to the distal oxygen atom of the 
heme-bound dioxygen in P450CAM. 
1.3.1 Role of Cys as Proximal Heme Ligand 
The heme in P450 enzymes is of the heme-b type, where the iron protoporphyrin-
IX is covalently linked to the protein backbone via a Fe-S bond to cysteine. In the case of 
P450CAM, Cys357 serves as the cysteine residue as seen in Figure. 1.1. The proximal 
cysteine thiolate ligand is indispensible for P450 catalytic activity and mutation of the 
cysteine residue leads to loss of activity.
23
 In the P450 catalytic cycle, one electron 
reduction of the oxyferrous state followed by protonation of the distal oxygen leads to the 
ferric-hydroperoxo intermediate. A second protonation of the ferric-hydroperoxo 
intermediate followed by heterolytic cleavage of the OO bond leads to formation of Cpd 
I, which is the primary oxidant in the cycle. Maintaining the cysteine as a thiolate anion 
on the proximal side of the heme at the same time as the iron in the ferrous state is crucial 













The thiolate anion is stabilized by H bonds from the protons of the adjacent residues, Leu 
358 (3.5 Å), Gly 359 (3.3 Å), Gln 360 (3.3 Å). Mutation of these residues led to 




Dawson and coworkers suggested that the polarizable nature of the cysteine 
thiolate anion ligand provides a strong ‘push’ of electron density via the heme onto the 
OO bond of the ferric-hydroperoxo intermediate, thus promoting heterolytic OO bond 
cleavage.
27, 28
 Furthermore, the electron-donating nature of the thiolate ligand also helps 
to stabilize the resulting Cpd I intermediate. This result is similar to the effect seen in 
cytochrome c peroxidase that contains a partially deprotonated proximal histidine ligand, 
wherein the imidazolate ‘push’ in concert with a ‘pull’ from the conserved distal His-Arg 
amino acids lead to heterolytic cleavage of the OO bond to generate Cpd I. 
1.3.2 Role of the Acid-Alcohol Pair in Oxygen Activation 
An acid-alcohol pair that is highly conserved in almost all P450 enzymes aids 
oxygen activation in the distal heme pocket. The alcohol in most cases is threonine or 
serine and the acid can be aspartate or glutamate. In the case of P450CAM, these residues 
are Asp251-Thr252. Given their highly conserved nature and proximity to the heme-
dioxygen binding site, the role of this acid-alcohol pair in catalysis has been examined in 
several mutagenesis studies. Specifically, the role of Thr was investigated by changing 
the residue to Ala. In P450CAM, the Thr252Ala mutant was almost completely 
uncoupled, leading to normal NADH and O2 consumption but essentially no product 
formation.
18, 29
 Based on this result in P450CAM and other P450s as well,
30, 31
 the alcohol 






 Ishimura and coworkers demonstrated that the uncoupling 
reaction is promoted when the Thr in P450CAM is mutated to a Ser or Asn, thereby 
ascertaining the role of Thr in stabilizing the H-bonding network in the distal pocket and 
controlling proton delivery to the distal oxygen of bound dioxygen.
22
 The Thr252Ser and 
Thr252Asn mutant enzymes retained more than half of the hydroxylating capability of 
the enzyme. The Thr252 residue also participated in H-bonding with the distal oxygen of 
the oxyferrous-P450 complex in P450CAM.
33
 The high-resolution crystal structure of the 
P450CAM Thr252Ala mutant showed a clearly perturbed H-bonding network and excess 
water molecules in the active site.
32
 It is thought that this perturbation leads to uncoupling 
due to incorrect delivery of the second proton to the proximal oxygen.
34
 Just as in 
P450CAM, the Thr268 in P450BM3 has been shown to play an important role in 
sustaining the proton pathway from the bulk solvent to the dioxy-bound heme. Mutation 
of Thr268 to Ala also leads to uncoupling followed by reduced substrate oxidation.
30, 35
 
Unlike the alcohol residue, the acid residue has an important role in electron 
transfer following oxyferrous intermediate formation. In P450CAM, the mutagenesis of 
Asp251 to Asn leads to decreased turnover in the mutant enzyme rather than 
uncoupling.
36, 37
 The Asp251Asn mutant displays an increased kinetic solvent isotope 
effect compared to the wild-type enzyme and a directly linear correlation to NADH 
consumption on bulk proton concentration, indicating that the proton delivery pathway 
has been modified in the Asp251Asn mutant.
36
 Structural analysis of the Asp251Asn 
mutant reveals significant changes in the active site. The Asn251 and Lys178 side chains 
rotate away from the active site and the Asn251 H-bonds to Asp182, causing open access 
to the heme.
36




plays an important role in dioxygen scission in P450CAM and suggests a similar role for 
the conserved acid functionality in other P450 enzymes. 
1.4 Multiple Oxidants in P450 Catalysis 
Although the P450s are a single family of enzymes, the wide variety of substrates 
oxidized by P450 is quite astounding. The catalytic cycle of P450s has been well 
established based on P450CAM as the prototype. The key catalytic intermediates have 
been detected and well characterized. Even the ferryl Cpd I intermediate, initially thought 
to be too short lived to detect has now been well characterized.
38
 Despite the fact that this 
intermediate has not been detected in the normal P450 catalytic cycle, it has been 
observed in the peroxide shunt pathway and there is little doubt about its involvement in 
substrate oxidation. While the ferryl Cpd I intermediate is thought to be the oxidant of 
choice in most oxidation reactions, the nature of certain catalytic intermediates and 
comparison with analogous reactions catalyzed in other enzyme systems make it difficult 
to deny the existence of multiple oxidizing species in the catalytic cycle. As seen in 
Scheme 1.3, several reaction intermediates other than Cpd I are thought to be capable of 






Scheme 1.3 Multiple P450 oxidants and types of reactions catalyzed. 
1.4.1 The P450 Dioxygen Complex 
In P450 enzymes, binding of dioxygen to the ferrous heme traps O2 for substrate 
oxidation. This generates the ferrous-dioxygen complex (Fe
+2
-OO), which is in resonance 




) (Fig. 2, 4). The binding constant of 










 The oxyferrous complex of P450s is 
not as stable as that of oxygen carrier proteins. In P450CAM, it is moderately stable in 





 The oxyferrous-P450 complex is similar to that of many of the 
analogous hemeproteins such as myoglobin, hemoglobin, CPO, NOS, etc.
41-44
 The 
oxyferrous stretching band of oxyferrous P450CAM as determined by resonance Raman 
spectroscopy is 1141 cm
1
, which is typical for superoxide complexes.
45
 Using 
cryocrystallization, the oxyferrous complex of P450CAM was determined at atomic 
















































Scheme 1.4 Oxyferrous complex of P450-CAM determined using PDB file 1DZ8.
9
 
The oxygen is coordinated to the heme iron in a slightly bent fashion with the Fe-OO 
angle being 142
o
. The oxyferrous complex is stabilized with the aid of a H-bond between 
the distal oxygen and hydroxyl of the nearby Thr252 residue. While the oxyferrous 
complex by itself is not known to catalyze any oxidation reaction, its formation is 
necessary to generate the subsequent catalytic intermediates in the reaction cycle.  
1.4.2 Ferric-peroxo Intermediate as a Nucleophilic Oxidant 
 Akhtar and coworkers first proposed a role for the ferric-peroxo intermediate in 
the final step of oxidative deformylation catalyzed by lanosterol 14 -demethylase.
46, 47
 
The enzyme catalyzes the oxidative deformylation of lanosterol, concomitantly forming 
olefin in three oxidative steps, and each step utilizing a single equivalent of NADPH and 
O2 as seen in Scheme 1.5. The final step results in cleavage of the C14C32 bond with 
stereoselective removal of 15-H, resulting in the formation of a 14,15 double bond and 
release of formic acid. The proposed mechanism involves homolytic cleavage of the O–O 
bond in a peroxy-aldehyde adduct to give an alkoxy free radical that decays to the olefin 
















Scheme 1.5 Mechanism of oxidative deformylation catalyzed by lanosterol 14α-
demethylase, see Ref. 47. 
Similar mechanisms have also been proposed for demethylation in estrogen formation by 
aromatase (CYP19A1) and in the CYP17A1-catalyzed CC bond scission of 17-
hydroxyprogesterone.
47, 48
 The formic acid formed in these P450-catalyzed oxidative 
deformylations has been shown to retain the original carbonyl oxygen and hydrogen as 
well as an atom from molecular oxygen, clearly pointing to the involvement of the ferric-
peroxo intermediate in the mechanism. In the CYP17A1 (17-hydroxylase-17,20-
lyase)catalyzed reaction, oxygen labeling experiments also point to homolytic scission 
of the OO bond in the peroxo-substrate adduct.
49
 Vaz and coworkers analyzed the 
elimination reaction of the aliphatic aldehyde in the rabbit drug-metabolizing CYP2B4 
enzyme. These reactions also seem to corroborate the involvement of peroxy anion-
supported homolytic scission, followed by fragmentation of the adduct into a carbon 
radical and a formyl species that yields olefin products.
50




























this mechanism is found when the carbon radical formed during the reaction inactivates 
the heme in P450.
51, 52
 
The electrophilic nature of aldehydes makes them easily susceptible to attack 
from the nucleophilic peroxy anion. Such an example of nucleophilic attack is also seen 
in nitric acid synthase (NOS) (Scheme 1.6). NOS is a heme-containing enzyme that 
catalyzes the conversion of arginine to N-hydroxyarginine and then to citrulline and nitric 
oxide. The second step of this reaction has been proposed to involve nucleophilic 
addition of the ferric-peroxo species to the –C=NOH bond of the substrate.
53
 Inorganic 
metalloporphyrins mimicking the ferric-peroxo intermediate have also been shown to 














































1.4.3 The Ferric-hydroperoxo Intermediate as an Electrophilic Oxidant 
The ferric-hydroperoxo intermediate has been proposed as an oxidant in catalysis 
involving nucleophilic substrates. However, unlike in the case of the ferric-peroxo 
intermediate, the hypothetical involvement of the ferric-hydroperoxo species in oxidative 
catalysis is not supported by solid evidence. Given the electrophilic nature of most 
substrates oxidized by P450s, Cpd I is the clear favorite oxidant in these cases due to its 
high reactivity. The most compelling evidence for involvement of the ferric-hydroperoxo 
intermediate was demonstrated via substrate oxidation by active-site mutants in P450s. In 
P450CAM, the Thr252 alcohol side chain was mutated to Ala and the resulting 
Thr252Ala mutant was unable to catalyze the hydroxylation of camphor. Instead, the 
mutant was highly capable of accepting electrons from the nucleotide cofactor to convert 
dioxygen to hydrogen peroxide (Scheme 1.2, II).
18, 29
 Improper protonation to the 
proximal oxygen of the ferric-peroxo intermediate thus leads to uncoupling. This mutant 
is, therefore, unable to form Cpd I but generates both the ferric-peroxo and ferric-
hydroperoxo intermediates. ENDOR spectroscopic analysis of the cryoreduced 
Thr252Ala mutant shows a buildup of the ferric-hydroperoxo intermediate at 77 K. 
Annealing at high temperatures yields the ferric enzyme but no hydroxylated product.
56, 57
 
As such, the Thr mutant of several P450s has been used in the study of a number of 
electrophilic oxidation reactions.  
Vaz, Coon and coworkers were the first to study the effects of the active-site Thr 
to Ala mutation in rabbit drug-metabolizing CYP2B4 and CYP2E1 enzymes using 
various alkene substrates (Scheme 1.7).
58




oxidation of the alkenes. In contrast, the Thr303Ala mutation in CYP2E1 significantly 
increased the rates of epoxidation compared to the wild-type enzyme.  
 
 
Scheme 1.7 Possible epoxidation reaction products in P450 enzymes.   
On the other hand, the corresponding Thr302Ala mutant of CYP2B4 demonstrated 
reduced rates of both allylic hydroxylation and epoxidation. Increased epoxidation versus 
allylic hydroxylation was observed in the CYP2E1 Thr303Ala mutant and was construed 
as evidence that epoxidation could be catalyzed by the ferric-hydroperoxo intermediate, 
while decreased Cpd I formation led to decreased hydroxylation. However, failure to 
observe similar results with CYP2B4 along with high quantities of hydroxylated product 
made the data somewhat less reliable, apparently because Cpd I was still being generated 
to a significant extent.  
Dawson and coworkers, in collaboration with the Sligar laboratory, studied the 
reactivity of the ferric-hydroperoxo intermediate in the Thr252Ala mutant of P450CAM 
using the alkene epoxidation reaction. Unlike the CYP2B4 and CYP2E1 enzymes, the 
Thr252Ala P450CAM mutant catalyzed the formation of less than 1% of the 
hydroxylated product, thus providing a more robust system to analyze the presence of a 
second oxidant, in this case the ferric-hydroperoxo intermediate. Both substrates were 
easily oxidized to epoxides (Scheme 1.8) at a rate of ~1520% compared to that of wild-
type P450CAM.
59






the involvement of a second electrophilic oxidant. Shaik and coworkers examined alkene 
epoxidation in the context of the two-state reactivity theory involving Cpd I
60, 61
 and 
proposed that the ferric-hydroperoxo species is a sluggish oxidant compared to the highly 
reactive Cpd I species. The researchers concluded that the ferric-hydroperoxo species has 
a large energy barrier to overcome, whereas ferric-hydroperoxo conversion to Cpd I is 
barrierless.
62
 P450 reactivity also appears to be influenced by H-bonding to the proximal 





Scheme 1.8 Olefin epoxidation by P450 CAM, see Ref. 59. 
P450 reactivity is also proposed to be influenced by changes in the relative amounts of 
high-spin and low- spin Cpd I, rather than amounts of the ferric-hydroperoxo and Cpd I 
species.
62
. However, the ‘two-state’ reactivity theory cannot clearly explain why the 
Thr252Ala mutant does not hydroxylate camphor. If the Cpd I oxidizing species only 
displays variation in the amounts of high-spin and low-spin states, the mutant enzyme 
should have displayed significant hydroxylation activity.  
The ferric-hydroperoxo intermediate has also been investigated as a potential 
oxidant in heteroatom oxidations. Jones and coworkers have looked particularly at 










design and the Thr268Ala mutant, the researchers sought to test whether the two products 
originated from the same oxidant species (Scheme 1.9).
65
 Thus, substrate 10a showed 
four times increased sulfoxidation activity compared to N-dealkylation activity. Next, the 
investigators used an isotopically-sensitive N-dealkylation substrate, 10b, to test the 
premise that due to a large kinetic isotope effect (KIE), sulfoxidation activity would be 
higher than N-dealkylation activity if both products arose from a single oxidant. 
 
 
Scheme 1.9 Heteroatom oxidation by P450 BM3, see Ref. 65.  
However, a negligible KIE was observed leading to several possible conclusions: (1) both 
products arose from different oxidants, (2) binding of substrate to the P450BM3 enzyme 
caused an interchange in the position of substituents, thereby changing their position in 
the catalytic site, and (3) the inherent KIE of N-dealkylation was very small. Using 
substrate 11, the researchers were able to demonstrate the rapid interchange of 
substituents at the end of the molecule. This result combined with an intramolecular KIE 
for substrate 10c eliminated the last two possibilities, leading to the proposal that both the 







































suggested that N-dealkylation was a product of Cpd I-mediated oxidation while 
sulfoxidation likely involved the ferric-hydroperoxo intermediate, without eliminating the 
possibility that the data could result from different forms of the same active oxygen 
species i.e Cpd I. In accordance with the ‘two-state’ state theory, where the low spin and 
high spin states form different enzyme-substrate (ES) complexes, the N-dealkylation and 
sulfoxidation reactions products can result from two non-interchangeable ES 
complexes.
63, 65
 Watanabe has also proposed that the altered reactivity in the active site 
threonine to alanine mutants may be a result of the altered water molecule network in the 
active site, which affects the hydrogen bonding of the Cpd I-ES complex.
66
 This 
alteration can skew the ratios of the low spin and high spin state of Cpd I, thereby 
affecting the mutant reactivity.  
The ferric-hydroperoxo species has also been implicated as an oxidant in 
hydrocarbon hydroxylation reactions. Catalysis by the ferric-hydroperoxo species was 
proposed to involve a cationic protonated alcohol intermediate
67
 (Scheme 1.10) as 




Scheme 1.10 Proposed hydrocarbon hydroxylation mechanism by the ferric-hydroperoxo 
species, see Ref. [67,68].   
Newcomb and coworkers used ‘radical clock’ experiments to provide evidence for 
involvement of a cationic intermediate.
67-71
 In the first of such studies, the oxidation of 




















could be oxygenated either on the methyl group yielding methyl alcohol as an 
unrearranged product or on the phenyl ring giving a ring-opened alcohol as a rearranged 
product. Using CYP2B1 as a biocatalyst, the substrate 12b was shown to generate a ring-






Scheme 1.11 Radical clock probes for mechanistic elucidation in CYP2B4, see Ref. 72. 
Reaction of substrate 12a with the CYP2B4 Thr302Ala mutant enzyme showed a mixture 
of products, both unrearranged and rearranged methyl oxidation as well as phenyl ring 
oxidation products. There was little difference in the ratio of rearranged to unrearranged 
product between the wild-type and mutant enzyme. However, a higher ratio of phenyl 
oxidation was seen in the mutant enzyme. The authors suggested that this result clearly 
indicated an alternative oxidant at play in the mutant enzyme that preferred the easier 
phenyl ring oxidation. To suppress phenyl ring oxidation in substrate 12b, the phenyl ring 
was replaced with an electron withdrawing CF3 group, which produced an altered ratio 
between the ring-opened and ring-closed products. This intimated a change in the oxidant 
in the hydroxylation reaction for that substrate. While these results satisfyingly conveyed 
involvement of the ferric-hydroperoxo species in the hydroxylation of certain substrates, 
the species is indeed a sluggish oxidant whereas Cpd I appears to be the oxidant of choice 
in hydrocarbon hydroxylations.
61
 While the ferric-hydroperoxo species appears in almost 











all heme-based oxygen activation enzymes, there are a few examples where it plays a 
primary role in substrate oxidation. For example, heme oxygenase catalyzes the oxidation 
of heme to biliverdin
73
 and the first step of this oxidation involves an -meso-
hydroxylation of the heme group that is thought to be catalyzed by an electrophilic 
oxidant, most likely, the ferric-hydroperoxo intermediate.
74-76
 
1.4.4 Cpd I as the Most Powerful Oxidant 
The mechanism of oxidation in P450s has been established by comparison with 
other heme-based oxygen activating enzymes as well as spectroscopic characterization of 
the reaction intermediates. P450s are similar to other metalloenzymes such as NOS and 
chloroperoxidase (CPO) in that they all have heme coordinated to a cysteine thiolate 
ligand. P450s and NOS are oxidoreductases that activate molecular oxygen.
77, 78
 The 
P450s have long been presumed to oxidize substrates via a reactive porphyrin radical 
cation ferryl species known as Cpd I. Additional evidence for reactive intermediates was 
also collected by direct observation through a combination of various spectroscopic 
techniques.
79
 Based on the observed activation of P450s by hydrogen peroxide, alkyl 
hydroperoxides, periodate and iodosobenzene, oxygen activation was assumed to occur 
by a two-electron reduction of dioxygen to the level of H2O2 followed by formation of the 
ferryl intermediate as seen in heme-containing peroxidases.
80
 Synthetic 
metalloporphyrins could form a porphyrin radical cation (ferryl) species at low 
temperature in polar medium on reaction with peroxy acids and this intermediate had the 








Scheme 1.12 Cpd I formation in synthetic metalloporphyrins by peroxy acids, 
reproduced with permission from Groves, J. T. (2003) The bioinorganic chemistry of iron 
in oxygenases and supramolecular assemblies, Proc. Natl. Acad. Sci. U. S. A. 100, 3569-
3574, Copyright 2003 National Academy of Sciences, U.S.A.  
When the transfer of an oxygen atom from the peroxy acid to produce the ferryl 
intermediate occurs, then the substrate is referred to as an ‘oxygen-rebound’ substrate.
82
 
Cpd I has been well characterized in CPO
83
 and was thought to be elusive in P450s. 
However, recently, Green and coworkers were successfully able to directly observe Cpd I 
in CYP119A1 for the first time.
38
 Cpd I was formed in about 75% yield by the reaction of 
ferric CYP119A1 with m-chloroperbenzoic acid. The resulting Cpd I species could then 
hydroxylate CH bonds in lauric acid with an apparent rate constant of kapp = 1.1 x 10
7
. 
The Mossbauer spectrum of this Cpd I species was similar to that seen using Cpd I of 
CPO. The mechanism of oxygen transfer from Cpd I to form the hydroxylated product 
has been a hotly debated topic. The initially proposed concerted mechanism of oxygen 
insertion
84
 fell aside in favor of the two-step H atom abstraction/oxygen rebound 
mechanism
82
. As explained in subsection 4.3, the ferric-hydroperoxo intermediate has 
also been implicated as an oxidant in a few hydrocarbon hydroxylations. ENDOR 
spectroscopic studies with cryoreduced wild-type P450CAM and its active-site mutants 
provided compelling evidence in favor of H atom abstraction/hydroxyl rebound.
57
 Active 





intermediate in the P450CAM-camphor complex. The ferric-peroxo and ferric-
hydroperoxo intermediates were observed upon slowly warming to 119 K and were 
subsequently characterized by EPR and ENDOR spectroscopy. Around 200 K, the ferric-
hydroperoxo species was quantitatively converted to 5-exo-hydroxycamphor, the natural 
product of camphor hydroxylation. While the ferryl intermediate was not observed 
directly, this oxidation was assumed to proceed through the hydroxyl intermediate 
because of the following observations in the experiment. After formation of the ferric-
hydroperoxo species upon slowly warming of the sample, the first species observed had 
the hydroxyl group bound to the heme iron, as was expected for the H atom abstraction in 
the ferryl-involved mechanism. Had the ferric-hydroperoxo species been involved in the 
oxidation, it would have initially formed hydroxycamphor via hydroxy insertion of the 
distal oxygen atom of the ferric-hydroperoxo species. Hydroxycamphor would be 
required to displace the hydroxyl/water that was bound to heme, but this displacement 
reaction was implausible to occur at 200 K. Furthermore, ENDOR spectroscopy showed 
that the hydrogen attached to the hydroxyl oxygen in the hydroxycamphor product 
originated from the C-5 position of camphor, further supporting the ferryl mechanism. 
Involvement of the ferric-hydroperoxo species would have required this H atom to 
originate from the surrounding solvent.  
Shaik and coworkers examined the mechanism of hydrocarbon hydroxylation 
using theoretical calculations and proposed a two-state reactivity instead of two-oxidant 
reactivity.
85-88
 The researchers showed that the porphyrin radical cation ferryl species 
exists in two spin states, a quartet spin state and a doublet spin state that are close in 




states. The species in the doublet state can quickly collapse to the product in a barrierless 
reaction with no formation of an intermediate. This almost-concerted mechanism is aided 
by the increased interaction of the cysteine thiolate ligand with the heme iron, the push 
effect. On the other hand, the quartet state must overcome a significant energy barrier to 
form the product, thus allowing formation and rearrangements of radicals if any. The 
two-state reactivity model has provided a good explanation for the stereochemical 
scrambling and structural rearrangement resulting from the radical clock experiments. 
Direct observation and characterization of Cpd I has cemented the H atom 
abstraction/hydroxyl rebound mechanism of P450 enzymes.
89
 
1.4.5 FeIII(H2O2) as an Oxidant in Sulfoxidation Reactions 
As described earlier, Jones and coworkers, based on the oxidation of a substrate 
with both amine and thioether functional groups in P450BM3, proposed that two 
different oxidants can be responsible for their oxidation. The ferric-hydroperoxo species 
was proposed as the oxidant responsible for sulfur oxidation.
65
 In the same vein, De Voss 






Scheme 1.13 Fatty acid oxidation by P450BM3, arrows indicate sites of oxidation and 
stereochemistry of products formed, see Ref. 90. 




















Analysis of the products indicated that presence of the thioether functionality 
dramatically shifted the regiochemistry of the reaction. With substrates 13 and 14, the 
oxidation was distributed across the last three methylene groups. However, replacement 
of the second methylene group with sulfur resulted in the oxidation in 15 and 16 
occurring exclusively at the sulfur. Interestingly, the sulfoxides were S enantiomers 
whereas the alcohols were R enantiomers. While it was speculated that thioethers 
undergo unusual binding to yield S sulfoxides, it has been shown in the past that modified 
fatty acids undergo R oxidation exclusively.
90-92
 Substrates were also reacted with the 
P450BM3 Thr268Ala active-site mutant, based on previous studies showing that the 
mutant enzyme formed very little Cpd I and was able to accumulate the ferric-
hydroperoxo species.
18, 29, 30
 Despite the low turnover in the mutant for substrate 14, 
product distribution and enantioselectivity remained unchanged between the wild-type 
and mutant enzyme. This demonstrated that there occurred reduced Cpd I formation in 
the mutant. For the thia fatty acid substrates, negligible change was observed in the 
turnover, product distribution and enantioselectivity of the products between the products 
of the wild-type and mutant enzyme. The authors proposed that sulfur oxidation must be 
easily catalyzed by the ferric-hydroperoxo species, thereby enabling the mutant enzyme 
to form comparable amounts of product compared to that of the wild-type enzyme.
90
 
However, Shaik and coworkers have recently used theoretical calculations to 
show that the Fe
III
(H2O2) complex (Scheme 1.2, 9) is a very efficient oxidant for 





complex was shown to undergo a nucleophilic attack from the distal oxygen atom of the 




transfer (Scheme 1.14). The Fe
III
(H2O2) complex could also catalyze the oxidation on 
sulfur much faster than could Cpd I. The ferric-hydroperoxo intermediate, in contrast, 
had a high barrier via the homolysis pathway of oxygen insertion.
93
 This finding offers a 
new paradigm for sulfoxidation reactions in P450s and their synthetic monologues. 
 
 
Scheme 1.14 Fatty acid oxidation by P450BM3, arrows indicate sites of oxidation and 
stereochemistry of products formed, see Ref. 93. 
1.5 Conclusions  
The mechanistic complexity of P450 enzymes has been intensely debated for the 
last few decades. The recent direct observation of P450 Cpd I and resulting studies of its 
reactivity have provided strong support for the validity of the hydrogen atom 
abstraction/radical rebound mechansim. The role of the ferric-peroxo intermediate as a 
nucleophilic oxidant is also well established. The proposed role of the ferric-hyroperoxo 
intermediate as an electrophilic oxidant remains to be established. Its role as an oxidant 
has been proposed mainly based on turnover studies in P450 mutants with impaired 
ability to form Cpd I. A recent addition to this oxidant puzzle is the Fe
III
(H2O2) 
intermediate which has been proposed to be more active than Cpd I in thio-ether 
oxidation reactions. The two-state reactivity theory involving Cpd I has also provided 
some explanations for the disparate experimental data. Additional experimental and 
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PROBING HETEROATOM-CONTAINING SUBSTRATE OXIDATION IN P450-CAM 





The multiple oxidant hypothesis of P450 catalysis has been probed in this study 
using P450-CAM from Pseudomonas putida, a prototypical P450 enzyme. The oxidation 
of substrates is accomplished by a catalytic cycle via a series of intermediates generated 
sequentially at the active site. Of these intermediates, the iron(IV)-oxo porphyrin radical 
cation, also known as Compound I, is believed to be the ultimate oxidant. However 
according to several studies in different types of P450s, it has been shown that the 
peroxoferric and the hydroperoxoferric intermediates formed prior to the Compound I 
may also be responsible for substrate oxidations depending on the reactivity of the 
specific substrate. P450-CAM is a versatile catalyst that has been shown to catalyze many 
typical P450 reactions in camphor analog substrates. The active site threonine-252 to 
alanine (T252A) mutant of P450-CAM on reaction with camphor yields H2O2 and 
minimal 5-hydroxycamphor, presumably because it makes very little Compound I while 
still generating the peroxoferric and hydroperoxoferric species. This makes T252A P450-
CAM an ideal catalyst to probe the multiple oxidant hypothesis. Using primarily 
electrophilic substrates, including camphor analog substrates modified at the fifth 
position, we have compared the quantitative product formation between wild type (WT) 
and T252A P450-CAM to gain an insight in the multiple oxidant hypothesis. 
2.1 Cytochrome P450-CAM as Prototype  
Much of the current information about P450s has been achieved through 
extensive studies of P450-CAM from the camphor degrading bacterium Pseudomonas 
putida. P450-CAM, the first soluble P450 was discovered by Gunsalus and co-workers.
1
 




insight into the mechanistic details of the reaction cycle.
2
 Although P450-CAM shares 
less than 30% sequence identity with other P450s, the all-important aspects of active site 
are conserved in the enzyme.
3
 The active site lies buried deep within the protein with the 
hydrophobic inner environment of the protein surrounding the heme macrocycle as well 
as the substrate camphor. The conserved proximal cysteine residue C357, which tethers 
the heme to the protein, and the conserved acid-alcohol pair, D251-T252 are seen in the 
active site (Fig. 2.1A and B). The acid-alcohol pair has an important role to play in 
formation of the catalytic cycle intermediates. In wild-type P450-CAM enzyme the T252 
residue lies on the distal side of the heme and is implicated in the protonation of the outer 
oxygen atom in the ferric hydroperoxo species that leads to water being formed as a 
leaving group with concomitant formation of Compound I. In the mutant enzyme where 
the active site threonine 252 was changed to alanine (T252A), the catalytic cycle has 
been found to undergo a short circuit pathway (Scheme 2.1, A). In this case the second 
protonation happens incorrectly on the proximal oxygen on the hydroperoxo ferric 
intermediate leading to H2O2 formation. D251 is known to support the chain of water 
molecules that supply protons to the active site. Alteration of the D251 residue leads to 








Figure 2.1 A) Crystal structure of P450CAM showing the heme macrocycle (red) and the 
substrate camphor (yellow) deep within the protein (blue) at the active site.
5
 B) Active 
site of camphor-bound oxy-P450-CAM, showing conserved residues (Cys357, Glu366, 











Scheme 2.1 P450 reaction cycle and intermediates. A non-productive uncoupling 
pathway that involves species 9 is shown in the inside of the outer cycle. 
2.2 The Multiple Oxidant Hypothesis in P450 Catalysis 
The exact intermediate responsible for adding oxygen to the hydrocarbon 
substrate has now been affirmatively shown to be Compound I; however the possibility 
of existence of multiple oxidants in the catalytic cycle also has been under consideration 
for past few years.
7
 Scientists have used various techniques such as electron 


















































































spectroscopy following cryoreduction of the oxyferrous enzyme, stopped flow rapid scan 
experiments and rapid freeze-quench methods by mixing ferric enzyme with oxygen 
atom donors, P450-like inorganic models and theoretical calculations to experimentally 
characterize the catalytic cycle intermediates.
8-11
 In addition to Cpd I, scientists have 
looked at the reactivity of the peroxoferric intermediate (Scheme 2.1, 5) in nucleophilic 
reactions and the hydro-peroxoferric intermediate (Scheme 2.1, 6) in electrophilic 
reactions as shown in Scheme 2.2. 
 
 
Scheme 2.2 Multiple oxidants in the P450 reaction cycle and types of reactions catalyzed 
by them. 
Apart from reaction intermediates, Shaik and co-workers have proposed that the 
two states of Cpd I intermediate, i.e the high-spin and low-spin forms, are responsible for 
different reactions.
12
 While the peroxoferric intermediate involves a nucleophilic role for 












































nature. Based on the turnover experiments of camphor, the T252A mutant of P450CAM 
has shown to be ineffective at catalyzing the hydroxylation of camphor, Table 2.1.  
Table 2.1 Amounts of 5-exo-hydroxycamphor formed during turnover of WT and T252A 
P450-CAM with camphor, indicated as nmol product formed per nmol of P450 per min. 
 
 
In this study T252A P450CAM formed less than 2% of the oxidized product as 
compared to the WT. The T252A variant however, is capable of accepting electrons from 
NADH and reducing bound dioxygen to H2O2 (Scheme 2.1, pathway A).
13
 This indicates 
that the T252A mutant is essentially incapable of forming Compound I and thus, is a 
good system to study the reactivity of the preceding alternate non-ferryl oxidants. The 
T252-A active site mutant of P450-CAM and analogous mutants of other P450s have 
been widely studied to understand the role played by active site residues in dioxygen 
activation and substrate oxidation mechanism.
14-17
 The Dawson lab in collaboration with 
the Sligar lab first tested the reactivity of the T252A P450CAM mutant with camphor 
alkene analogues to look for the presence of alternate oxidants.
16
 Reaction with alkene 
substrates gave the corresponding epoxide products, however the rate of epoxidation was 
only 15-20% of the rate at which the wild-type enzyme oxidized the substrate. The higher 
rate of epoxidation as compared to that of camphor hydroxylation indicated that the 
T252A mutant could utilize hydroperoxoferric intermediate for epoxidation, but that 
Compound I remained the oxidant of choice in the wild-type enzyme for epoxidation. It 
also indicated that the hydroperoxoferric intermediate is a rather sluggish oxidant. 
P450-CAM WT T252A % of WT 




In order to further investigate the multiple oxidant hypothesis of P450 catalysis, 
we have studied the reaction between other electrophilic substrates and T252A P450-
CAM enzyme in this study. The substrates include camphor analogues containing 
reactive functional groups at C-5, which is the normal site of P450 catalyzed oxidation in 
camphor, and the corresponding functional groups in benzene substrates. Reactions of 
these substrates have been performed with both wild-type (WT) P450CAM as well as the 
T252A mutant using the fully reconstituted electron transfer system consisting of NADH, 
putidaredoxin (PdX) and putidaredoxin reductase (PdR). In this chapter, we report our 
findings from the quantitative comparison of the product formation between the WT and 
T252A to gain an insight into the multiple oxidant hypothesis.  
2.3 Experimental Methods. 
Expression and Purification of Proteins 
a) WT and T252A P450-CAM: Both the WT and T252A P450-CAM enzymes were 
purified according to protocol described in Dr. Glascock’s dissertation.
18
 TB1 stock cells 
of E. coli bearing the pEMBL P450CAM containing plasmid were streaked on a LB-
Ampicillin agar plate and incubated over night at 37
o
C. A single colony from this plate 
was used to inoculate a 100 mL of LB-Broth supplemented with ampicillin and the cells 
are grown until the OD600 is about 0.8. 10 mL of this solution was then added to 6-L LB-
broth supplemented with ampicillin and the cells are grown for 18 h. The cells are then 
harvested by centrifugation at 4
o 
C for 10 min at 5000 x g. The cells were finally washed 
with buffer containing 1 mM 1R-(+)-camphor, 50 mM potassium phosphate (KPi) at pH 
7.4 (buffer A). To purify the protein, the cell pellet was dissolved in buffer A as 




s. sonication intervals at 90% output with 2 min interval between sonication, while being 
stored on dry ice to prevent denaturation of the protein. The lysed cell debris was 
removed by centrifugation at 4
o 
C for 25 min at 10000 x g. The supernatant was loaded 
on a Whatman DE52 cellulose anion exchange column and washed with the 1 mM 1R-
(+)-camphor, 50 mM KCl, 50 mM KPi at pH 7.4 (buffer B). The protein was eluted by a 
linear KCl gradient from 50-250 mM KCl in buffer B. The purity of each sample was 
analyzed by measuring the UV-visible (UV-vis) absorbance at 391 nm over that at 280 
nm, the higher the ratio, better is the purity. To achieve higher purity, the protein was 
loaded onto a Biogel P-100 size exclusion column and eluted with 1 mM 1R-(+)-
camphor, 50 mM KCl, 50 mM KPi at pH 7.4 (buffer C). Fractions with UV-vis 
absorbance ratio A(391)/A(280) values greater than 1.4 were used for experimental work. 
Proteins in buffer B containing excess camphor were concentrated to ~1 mM, flash-
frozen in liquid nitrogen and stored at -80
o 
C.  
b) PdR and PdX: Dr. Thomas Poulos (University of California, Berkeley, USA) kindly 
provided overexpression systems for PdR and PdX enzymes. Expression and purification 
of these proteins were achieved as per published protocols with minor modifications.
19, 20
 
For both PdR and PdX, the cell lysis was achieved by sonication as described above for 
P450-CAM. For PdX, the two-step column purification was achieved by first loading the 
lysate on to a Whatman DE52 cellulose anion exchange column, followed by a Biogel P-
100 size exclusion column. Protein fractions with UV-vis absorbance ratio 
A(412)/A(280) values between 0.48-0.5 were used for experimental work. For PdR, the 




and the protein fractions with UV-vis absorbance ratio A(280)/A(454) values of 7.0 or 
less were used.  
Turnover Experiments: 
a) Camphor removal and buffer exchange: In order to perform turnover experiments, the 
P450-CAM enzymes had to be stripped of camphor. This was achieved using a Biogel 
P6DG desalting column equilibrated with 0.05 M MOPS buffer at pH 7.0, followed by 
buffer exchange on another Biogel P6DG desalting column equilibrated with camphor 
free buffer B. Successful removal of camphor was confirmed by a shift in the Soret 
absorbance from 391 nm to 417 nm.  
b) Substrates: Benzene derivative substrates, styrene and thioanisole were purchased 
from Sigma-Aldrich. 5-methylenylcamphor was synthesized by Shengxi Jin.
21
 (1R)-5-
exo-thiomethoxycamphor was newly synthesized according to the methods described by 
Kemnitzer 
22
 and Jin 
21
 with minor modifications as described in Scheme 2.3. All the 
intermediates and the final products of the synthesis were monitored by 
1
H-NMR and 







Scheme 2.3 Synthetic scheme for (1R)-5-exo-thimethoxycamphor.  
c) Catalytic turnover and NADH consumption experiments: Reaction mixtures were set 
up in 50 mM KPi pH 7.4 buffer containing a mixture of the P450CAM-WT (0.5 µM), 
PdX (10 µM), substrate (0.5 mM for camphor analogues and 1 mM for benzene 
analogues), and NADH (1.0 mM). Catalase (5 µM, based on heme) was used for benzene 
substrates. The reactions were initiated by adding PdR (4.0 µM). Reactions were carried 
out for 15 min. for the camphor analog substrates and 30 min. for the benzene substrates 
and were quenched by adding 1 mL CH2Cl2. Suitable internal standards were added to 
the reaction mix before extracting the products. To measure the kinetic solvent isotope 
effect (KSIE), the reaction was carried out in D2O KPi buffers (see above). Prior to the 
reaction, the P450-CAM enzymes were allowed to acclimatize in the buffer for at least 30 
min. To monitor the NADH consumption during thioether substrate oxidation, the 
turnover reaction was conducted in a 0.5 cm quartz cuvette and the decrease in absorption 































d) Calculation of product formed: Oxidized products were analyzed by GC-MS. The 
amount of products formed was quantitated using standard curves of the oxidized product 
and internal standard, 3-bromocamphor for camphor analog substrates and 4-tert-
butylphenol for benzene substrates.  
2.4 Results and Discussion 
In the first set of turnover experiments (Scheme 2.4), we looked at the products of 
the turnover reaction of 5-methylenylcamphor (Scheme 2.4, 10) and styrene (Scheme 2.4, 
12), followed by (1R)-5-exo-thiomethoxycamphor (Scheme 2.4, 14) and thioanisole 
(Scheme 2.4, 15) with the WT and T252A P450-CAM mutant enzymes. The two olefin-
containing substrates formed epoxide products (Scheme 2.4, 11 and 13) as has been 
demonstrated previously in WT P450-CAM.
16, 23
 However, of the two sulfur-containing 
substrates, thioanisole formed a sulfoxide (Scheme 2.4, 17) while the camphor analogue, 
[(1R)-5-exo-thiomethoxycamphor], underwent an oxidative dealkylation to form a ketone 
product (Scheme 2.4, 15). The results of the turnover experiments are summarized in 
Table 2.2 below. With the olefinic substrates, the rate of epoxidation of styrene in T252A 
P450-CAM was observed to be about 25% of the rate seen in WT P450-CAM. This value 
is similar to the results previously reported for camphor olefin.
16
 In similar reactions 
conducted in mammalian P450s, Coon and co-workers have reported similar findings and 




Oxidation of the two thiomethoxy substrates however, provided the most 
surprising results. Both in camphor analogue substrate (14) and benzene substrate (16), 




rate seen with WT enzyme. We then looked at the NADH consumption and calculated 





Scheme 2.4 Products of turnover reactions with olefins and thioethers catalyzed by P450-
CAM. 
Table 2.2 Amounts of products formed with WT and T252A camphor indicated as nmol 
product formed per nmol of P450 per min. 
Substrate P450CAM-
WT 









 22.9 ± 0.6
a
 21.4 % 
Styrene (12) 0.9 ± 0.2
a
 0.2 ± 0.1 24.4 % 
5-(1R)-exo-Thiomethoxy-
camphor (14) 
3.35 ± 0.6 1.79 ± 0.3  53.5 % 












 Amounts of product formed is in agreement with values published previously 
Table 2.3 Amounts of NADH consumed by turnover of P450 CAM with (A) 5-(1R)-exo-
thiomethoxycamphor (14) and (B) thioanisole (16) indicated as nmol NADH consumed 




P450-CAM WT P450-CAM T252A 
NADH consumed 61.4 ± 1.8 61.8 ± 2.7 
Product formed 3.35 ± 0.6 1.79 ± 0.3 
Coupling % 5.6 ± 1 2.9 ± 0.6 
Uncoupling % 94.5 ± 1 97.1 ± 0.6 
 
(B) Thioanisole (16) P450-CAM WT P450-CAM T252A 
NADH consumed 44.8 ± 0.6 12.23 ± 2.8 
Product formed 2.41 ± 0.2 1.65 ± 0.04 
Coupling % 5.4 ± 0.5 13.9 ± 2.6 
Uncoupling % 94.6 ± 0.5 86.0 ± 2.6 
  
Sulfoxidation was exclusively observed for thioanisole (16). Consistent with 
previously reported results, thioanisole was never observed to undergo S-dealkylation of 
the methyl group attached to the sulfur group.
24
 In the sulfoxidation reaction, the T252A 
mutant underwent oxidation at about 70% of the rate observed for that of the WT. It has 
been recently proposed by Shaik and co-workers that the Fe
III
-(H2O2) (9 in Scheme 2.1) 
complex could be a highly efficient oxidant in sulfoxidation reactions.
25




been proposed to occur by a nucleophilic attack from the distal oxygen atom of the Fe
III
-
(H2O2) complex resulting in heterolytic OO bond scission that is coupled to proton 









It is to be noted that the Fe
III
-(H2O2) complex is formed in the uncoupling pathway 
thereby correlating with the observed high turnover despite low NADH coupling in 
thioanisole sulfoxidation. Although Shaik and co-workers have proposed that Fe
III
-(H2O2) 
intermediate is more efficient than Cpd I in thioether oxidation, the higher rate of 
sulfoxidation by the WT enzyme suggests that Cpd I is still the strongest oxidant at play. 
Oxidation at the sulfur atom was not observed in the thiomethoxy camphor 
substrate (14). The reaction with the camphor analog is presumed to occur in two steps, 
first C-hydroxylation followed by S-demethylation (Scheme 2.6). The hydroxylated 
intermediate is too unstable to be observed and has never been seen as a detectable 
product in our turnover reactions. The T252A mutant is able to oxidize the substrate at a 
rate that is 60% of that seen with WT. For the camphor analogue, a higher coupling is 
observed in the WT enzyme, although the coupling in the mutant enzyme is only reduced 


























Scheme 2.6 P450 catalyzed oxidative demethylation reaction in 5-(1R)-
thiomethoxycamphor. 
Since the first step of this oxidation is C-hydroxylation, if Cpd I was the oxidant of 
choice, oxygen insertion would occur by the hydrogen atom abstraction-hydroxyl radical 
rebound mechanism. Davydov and co-workers have shown that little camphor 
hydroxylation in T252A proceeds via the ferryl intermediate,
26
 thus the higher 
hydroxylation rate in the T252A mutant as seen in our data strongly indicates that 
alternative oxidant(s) may be involved in reactions catalyzed by the mutant. The 
theoretical examination of the bond energies of the 5-(1R)-thiomethoxycamphor structure 
show that the presence of sulfur atom significantly weakens the C-H bond thus making it 
susceptible to attack from weaker oxidants as well (Shengxi Jin, Feng Xu, Vitaly 
Rassolov, John Dawson unpublished data). 
Given the electrophilic nature of these reactions, and the high rate of reaction with 
the T252A mutant which forms little Cpd I, either the ferric-hydroperoxo or Fe
III
(H2O2) 
species are likely to be involved in the oxidation. The Fe
III
(H2O2) species has been 
proposed to perform oxidation faster than it converts to Cpd I, thereby bypassing Cpd I in 
presence of thioether,
25
 although the camphor thioether analog does not undergo 
sulfoxidation. If the Fe
III
(H2O2) species is involved in the oxidative dealkylation and 
were to proceed by O-O cleavage, we hypothesize the hydroxyl insertion mechanism 















Scheme 2.7 Putative mechanism for oxidative demethylation of 5-(1R)-
thiomethoxycamphor reaction involving Fe
III
(H2O2) intermediate. 
Similarly, if the ferric-hydroperoxo was the involved in oxidation, the mechanism 
could occur by insertion of the distal oxygen to form protonated alcohol, followed by loss 
of proton to give a thio-hemiketal type intermediate. Loss of methanethiol results in 




Scheme 2.8 Putative mechanism for oxidative demethylation of 5-(1R)-
thiomethoxycamphor reaction involving ferric-hydroperoxo intermediate. 
Involvement of ferric-hydroperoxo intermediate in hydrocarbon hydroxylation has been 
unconvincing due to lack of compelling evidence. So far in nature, the only evidence for 















































oxidation of heme to biliverdin by the heme oxygenase (HO) enzyme.
27
 However the lack 
of well-defined catalytic residues in the HO active site have led to the proposal that such 
HO catalyzed oxidations may be an exception in cases where O-O bond scission to yield 
Cpd I is inefficient,
27, 28
 like in threonine to alanine mutations of P450s active sites.  
2.5 Conclusions  
The involvement of multiple oxidants in P450 catalysis stems from the idea of 
‘induced reactivity’ in which the substrate modulates the properties of a reactive 
intermediate.
29
 In this work, we have demonstrated that compared with the WT enzyme, 
the T252A P450-CAM mutant exhibits considerable reactivity toward heteroatom 
containing substrates. It is especially notable that in the case of thioether substrates, the 
relative oxidation rates are close to 50% the rate seen with the wild-type enzyme. Since 
the T252A P450-CAM mutant has almost no hydroxylation activity toward camphor, it is 
presumed to form little if any Cpd I and therefore its ability to carry out substrate 
oxygenations must be attributed to alternate reactive intermediates. In oxidation of the 
benzene derivative substrate, thioanisole, theoretical calculations have shown that the 
Fe
III
(H2O2) species can be an effective oxidant, even better than Cpd I. The involvement 
of other oxidants, possibly ferric-hydroperoxo or Fe
III
(H2O2) is further affirmed in the 
case of the T252A-camphor thioether substrate turnover as it undergoes hydroxylation 
followed by demethylation. Once again, since this mutant does not form significant 
amounts of Cpd I, its ability to carry out the S-demethylation reaction must be due to 
involvement of another reactive intermediate, presumably the ferric-hydroperoxo species. 
While the ferric-hydroperoxo intermediate may not be the oxidant of choice in the most 




oxygenate more reactive substrate such as the heteroatom-containing substrates examined 
herein.  
2.6 References.  
1. Gunsalus, I. C., and Sligar, S. G. (1978) Oxygen reduction by the P450 
monoxygenase systems, Adv. Enzymol. Relat. Areas Mol. Biol. 47, 1-44. 
2. Poulos, T. L., Finzel, B. C., Gunsalus, I. C., Wagner, G. C., and Kraut, J. (1985) 
The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450, J. Biol. Chem. 
260, 16122-16130. 
3. Nelson, D. R. (2011) Progress in tracing the evolutionary paths of cytochrome 
P450, Biochim. Biophys. Acta -Proteins and Proteomics 1814, 14-18. 
4. Gerber, N. C., and Sligar, S. G. (1994) A role for Asp-251 in cytochrome P-
450cam oxygen activation, J. Biol. Chem. 269, 4260-4266. 
5. Schlichting, I., Jung, C., and Schulze, H. (1997) Crystal structure of cytochrome 
P-450cam complexed with the (1S)-camphor enantiomer, FEBS Lett. 415, 253-257. 
6. Schlichting, I., Berendzen, J., Chu, K., Stock, A. M., Maves, S. A., Benson, D. E., 
Sweet, R. M., Ringe, D., Petsko, G. A., and Sligar, S. G. (2000) The Catalytic Pathway of 
Cytochrome P450cam at Atomic Resolution, Science 287, 1615-1622. 
7. de Montellano, P. R. O., and De Voss, J. J. (2002) Oxidizing species in the 
mechanism of cytochrome P450, Nat. prod. rep. 19, 477-493. 
8. Sono, M., Eble, K. S., Dawson, J. H., and Hager, L. P. (1985) Preparation and 
properties of ferrous chloroperoxidase complexes with dioxygen, nitric oxide, and an 
alkyl isocyanide. Spectroscopic dissimilarities between the oxygenated forms of 




9. Spolitak, T., Dawson, J. H., and Ballou, D. P. (2005) Reaction of Ferric 
Cytochrome P450cam with Peracids: Kinetic chracterization of intermediates on the 
reaction pathway, J. Biol. Chem. 280, 20300-20309. 
10. Davydov, R., Macdonald, I. D. G., Makris, T. M., Sligar, S. G., and Hoffman, B. 
M. (1999) EPR and ENDOR of Catalytic Intermediates in Cryoreduced Native and 
Mutant Oxy-Cytochromes P450cam:  Mutation-Induced Changes in the Proton Delivery 
System, J. Am. Chem. Soc. 121, 10654-10655. 
11. Meunier, B., de Visser, S. P., and Shaik, S. (2004) Mechanism of Oxidation 
Reactions Catalyzed by Cytochrome P450 Enzymes, Chem. Rev. 104, 3947-3980. 
12. Shaik, S., Filatov, M., Schröder, D., and Schwarz, H. (1998) Electronic Structure 
Makes a Difference: Cytochrome P-450 Mediated Hydroxylations of Hydrocarbons as a 
Two-State Reactivity Paradigm, Chemistry – A European Journal 4, 193-199. 
13. Imai, M., Shimada, H., Watanabe, Y., Matsushima-Hibiya, Y., Makino, R., Koga, 
H., Horiuchi, T., and Ishimura, Y. (1989) Uncoupling of the cytochrome P-450cam 
monooxygenase reaction by a single mutation, threonine-252 to alanine or valine: 
possible role of the hydroxy amino acid in oxygen activation, Proc. Natl. Acad. Sci. U S 
A 86, 7823-7827. 
14. Martinis, S. A., Atkins, W. M., Stayton, P. S., and Sligar, S. G. (1989) A 
conserved residue of cytochrome P-450 is involved in heme-oxygen stability and 
activation, J. Am. Chem. Soc. 111, 9252-9253. 
15. Vaz, A. D. N., McGinnity, D. F., and Coon, M. J. (1998) Epoxidation of olefins 
by cytochrome P450: Evidence from site-specific mutagenesis for hydroperoxo-iron as an 




16. Jin, S., Makris, T. M., Bryson, T. A., Sligar, S. G., and Dawson, J. H. (2003) 
Epoxidation of Olefins by Hydroperoxo−Ferric Cytochrome P450, J. Am. Chem. Soc. 
125, 3406-3407. 
17. Cryle, M. J., and De Voss, J. J. (2006) Is the ferric hydroperoxy species 
responsible for sulfur oxidation in cytochrome p450s?, Angew. Chem. Int. Ed. Engl. 45, 
8221-8223. 
18. Glascock, M. C. (2003) PhD, In Dissertation, p 183, University of South 
Carolina, Columbia, SC, USA. 
19. Sevrioukova, I. F., Garcia, C., Li, H., Bhaskar, B., and Poulos, T. L. (2003) 
Crystal Structure of Putidaredoxin, the [2Fe–2S] Component of the P450cam 
Monooxygenase System from< i> Pseudomonas putida</i>, J. Mol. Biol. 333, 377-392. 
20. Sevrioukova, I. F., Hazzard, J. T., Tollin, G., and Poulos, T. L. (2001) Laser flash 
induced electron transfer in P450cam monooxygenase: putidaredoxin reductase-
putidaredoxin interaction, Biochemistry 40, 10592-10600. 
21. Jin, S. (2005) PhD, In Dissertation, p 55, University of South Carolina, Columbia, 
SC, USA. 
22. Kemnitzer, W. E. (1998) PhD, In Dissertation, p 30, University of South 
Carolina, Columbia, SC, USA. 
23. Fruetel, J. A., Collins, J. R., Camper, D. L., Loew, G. H., and Ortiz de 
Montellano, P. R. (1992) Calculated and experimental absolute stereochemistry of the 
styrene and. beta.-methylstyrene epoxides formed by cytochrome P 450cam, J. Am. 




24. Fruetel, J., Chang, Y.-T., Collins, J., Loew, G., and Ortiz de Montellano, P. R. 
(1994) Thioanisole sulfoxidation by cytochrome P450cam (CYP101): experimental and 
calculated absolute stereochemistries, J. Am. Chem. Soc. 116, 11643-11648. 
25. Wang, B., Li, C., Cho, K.-B., Nam, W., and Shaik, S. (2013) The FeIII(H2O2) 
Complex as a Highly Efficient Oxidant in Sulfoxidation Reactions: Revival of an 
Underrated Oxidant in Cytochrome P450, J. Chem. Theor. Comp. 9, 2519-2525. 
26. Davydov, R., Makris, T. M., Kofman, V., Werst, D. E., Sligar, S. G., and 
Hoffman, B. M. (2001) Hydroxylation of Camphor by Reduced Oxy-Cytochrome 
P450cam:  Mechanistic Implications of EPR and ENDOR Studies of Catalytic 
Intermediates in Native and Mutant Enzymes, J. Am. Chem. Soc. 123, 1403-1415. 
27. Wilks, A., Torpey, J., Ortiz de Montellano, P. R. (1994) Heme oxygenase (HO-1). 
Evidence for electrophilic oxygen addition to the porphyrin ring in the formation of 
alpha-meso-hydroxyheme, J. Biol. Chem. 269, 29553-29556. 
28. Schuller, D. J., Poulos, T. L., Wilks, A., and Montellano, P. O. D. (1998) 
Crystallization of recombinant human heme oxygenase‐ 1, Protein Sci. 7, 1836-1838. 
29. Kim, S. H., Yang, T.-C., Perera, R., Jin, S., Bryson, T. A., Sono, M., Davydov, 
R., Dawson, J. H., and Hoffman, B. M. (2005) Cryoreduction EPR and 13C, 19F 
ENDOR study of substrate-bound substates and solvent kinetic isotope effects in the 
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Magnetic circular dichroism  (MCD) spectroscopy also known as the Faraday 
effect is an excellent fingerprinting tool for various heme systems. It can be used for 
assigning axial ligand identity, coordination numbers as well as spin state determination 
of the heme iron, which can lead to important information about their structures and 
functions. Over the past 30 years, the Dawson laboratory has recorded and maintained a 
library of MCD spectra of numerous heme proteins from various collaborative projects 
and their own studies. Continuing the collaborative work, in this chapter we present 
results from the application of MCD spectroscopy in the axial ligand(s) identification 
analysis of three novel heme proteins, sGAF2, Z-ISO and Phu_R, and in characterization 
of the ferrous dioxygen complex of an engineered P450BM3 protein. 
3.1 Magnetic Circular Dichroism Spectroscopy 
Studies of the coordination structures of heme protein active sites provide 
important information about the mechanism of action of the native heme proteins. 
Particularly, the amino acids coordinating to the heme iron and those surrounding the 
active site along with the oxidation and spin states of the heme iron have been shown to 
play important roles in the structure and function of heme-proteins.
1-3
 Magnetic circular 
dichroism (MCD) has long been used in the Dawson laboratory as a fingerprinting 
technique for various heme systems. The theory of MCD is based on the Faraday effect 
first discovered by Michael Faraday in 1845. Natural circular dichroism (CD) and MCD 
both measure the difference in absorption between left and right circularly polarized 
light. In MCD a magnetic field is applied parallel to the direction of propagation of 
light.
4-8




dissymmetry within the structure of the chromophore (chirality) or environment. 
According to the Faraday effect, the application of a magnetic field parallel to the 
direction of light induces optical activity due to Zeeman splitting. Therefore all species 
can exhibit MCD spectra while only the optically active species can exhibit CD spectra.  
Both CD and MCD signals can only be observed in the regions displaying 
electronic band absorption. An MCD spectrum is composed of several bands arising from 
different electronic transitions, and these bands are composed of three separate, ‘A’, ‘B’ 
and ‘C’ terms Fig. 3.1.
9
 ‘A’ terms are temperature independent and have a typical 
derivative-shaped dispersion centered on the electronic absorption spectrum band. ‘A’ 
terms are seen only in those systems that demonstrate degeneracy in excited state that is 
lifted by the applied magnetic field, also known as Zeeman splitting and as such they are 
typically seen in spectra of systems exhibiting a three-fold or higher symmetry axis. ‘B’ 
terms arise from magnetic field-induced ground state and excited state mixing, typically 
seen in systems with less than three fold symmetry. They are Gaussian-shaped and are 
temperature independent similar to the ‘A’ terms. ‘C’ terms are temperature-dependent, 
arising from magnetic field-induced lifting of ground state degeneracies. This causes the 








Figure 3.1 Diagram illustrating the origin of the A, B, and C terms of a MCD spectrum, 
reprinted with permission from Vickery, L. E. (1978) Spin states of heme proteins by 





It has been shown that MCD is a powerful probe of the heme iron spin state, 
oxidation state, and the identity of the heme iron axial ligand(s) while being relatively 
insensitive to the surrounding factors other than the axial ligands.
12, 13
 MCD spectra can 
be recorded over a range of temperatures, on dilute samples even in the micromolar range 
(10
-6 
M) and on both diamagnetic and paramagnetic species.
13, 14
 Unlike the traditional 
UV-visible (UV-vis) absorption spectra, which only have positive sign features, MCD 
spectra have both positive and negative sign features, thereby presenting a finer 
electronic structural detail of the system being investigated. This ‘fingerprinting’ capacity 
combined with the intrinsic sensitivity to the electronic (and thus structural) aspects of 
the chromophore being examined and relative insensitivity of environmental factors 
makes MCD an extremely useful tool for coordination structural elucidation. MCD 
spectroscopy’s potential applications include: 
a) To determine ground state magnetic properties such as spin state, g-values, zero 
field splittings and magnetic coupling; 
b) To assign electronic transitions pertaining to the electronic structure of a 
chromophore, including theoretical models; 
c) To resolve individual components of electronic spectra of proteins containing 
several metal centers; and, 
d) To compare novel proteins to model systems or vice-versa to determine the active 
site coordination structure with regards to ligands, spin state, oxidation state, geometry, 





Having introduced the theory and basic uses of MCD spectroscopy, in this chapter 
we will look at the application of MCD in the determination of axial ligand identity in 
novel heme proteins, sGAF2, Z-ISO and Phu_R, and in the characterization of the 
dioxygen complex of an engineered P450BM3 protein. 
3.2 Part A: Axial Ligand Determination in sGAF2 
The protein MA4561 from the methanogenic archaeon Methanosarcina 
acetivorans was predicted to be a phytochrome-like photoreceptor mainly because of the 
presence of a conserved cysteine residue in the first GAF domain.
15
 However the 
recombinantly produced and purified protein was shown to not bind any known 
phytochrome chromophores, instead UV-vis absorption spectroscopy revealed the 
presence of a heme tetrapyrrole cofactor. The heme is covalently attached via one vinyl 
side chain to cysteine 656 in the second GAF domain. Majority of the heme-based 
sensors have a heme-b type non-covalently attached tetrapyrrole cofactor, but pyridine 
hemochromogen assay revealed that the α-band maximum in MA4561 is at 553 nm. This 
is typically seen in c-type cytochromes due to the saturation of only one heme vinyl 
group, whereas the other stays unsaturated.
16, 17
 Functionally MA4561 has been proposed 
to be a heme-based sensor kinase that is able to autophosphorylate methyl sulfide 
methyltransferase depending on the heme redox state.
18
 In order to get a better 
understanding of the heme co-ordination structure, Prof. Nicole Frankenberg-Dinkel 
(Ruhr-University, Bochum, Germany) collaborated with our laboratory for MCD studies 
of the heme domain containing MA4561 variant, sGAF2. 
3.2.1 Methods: 




prepared as described in.
18
 MCD spectra were measured on a Jasco J815 
spectropolarimeter fitted with a Jasco MCD-1B magnet at a magnetic field strength of 
1.41 T at 4° C using a 0.2 cm path length quartz cuvette. Jasco software was used for data 
acquisition and manipulation as reported previously.
19
 Because the molar absorptivity of 
the pyridine hemochromogen of the heme in variant sGAF2-His6 (without imidazole 
(Im)) could not be determined, concentrations of the sGAF2 samples were tentatively 




 (the value for ferric 
cytochrome b5) for the Soret absorption peak (415 nm) of the Im complex of ferric 
sGAF2 at pH 7.0. UV-vis absorption spectra were recorded on Cary 400 spectrometer, 
before and after each MCD measurement to track sample integrity. sGAF2 protein 
samples were studied in 50 mM sodium phosphate buffer containing 100 mM NaCl 
(NaPi) at pH 7.0 and in 50 mM CAPS buffer at pH 10.0. The Im and tetrahydrothiophene 
(THT) adducts were prepared by adding 2 and 14 mM Im and THT to the ferric protein, 
respectively. The ferrous species of sGAF2 was prepared from ferric protein in the 
presence or absence of exogenous ligands (Im and THT) by flushing a rubber septum-
sealed cuvette with nitrogen gas for about 10-15 min followed by the addition of a small 
amount of solid sodium dithionite. 
3.2.2 Results and Discussion:  
MCD spectra of ferric and ferrous states of sGAF2 are shown in Fig. 3.2, where 
the spectra of analogous states of horse heart myoglobin (Mb), horseradish peroxidase 
(HRP) and cytochrome b5 (cyt b5) are overlaid for comparison. All of these three 
proteins contain His-ligated heme (iron-protoporphyrin IX) prosthetic group. At pH 7.0 




– 700 nm) that is similar to that of ferric HRP (dashed line) and ferric Mb (dotted line), a 
five-coordinate and water-ligated six-coordinate heme respectively. However, a closer 
comparison of the trough intensities at ~640 nm indicates that the spectrum of ferric 
sGAF2 is more similar to that of HRP than Mb. In the Soret region (350 – 450 nm), an 




























) of ferric Mb. These comparisons suggest the heme group in ferric sGAF2 at pH 7.0 
is more likely to be five-coordinate rather than six-coordinate. The MCD spectrum of 
ferric sGAF2 at pH 10.0 (gray line) is clearly different from that at pH 7.0 in that one of 
the visible region trough (~550 nm) is shifted to ~575 nm and a Soret region feature 







The resultant spectral features are indicative of an increased low spin six-coordinate 
species.  
Dithionite-reduced ferrous state sGAF2 (solid line in Fig. 3.2B) has MCD spectral 
features that are broadly similar to those of ferrous Mb (which contains a His-ligated 







) except for the more enhanced and derivative-like shape in the visible region 
around 555 nm for sGAF2 compared to Mb. At pH 10.0, this derivative-shaped spectral 
line becomes much more intense. Concomitantly, the Soret peak intensity diminishes by 
~50% (gray line in Fig. 3.2B). These MCD spectral changes are indicative of an increase 




ligated ferrous heme (see below). Fig. 3.3C compares ferric-Im (solid line) and ferric-
THT (a cyclic thioether) adducts (dashed line) of sGAF2 with ferric cyt b5 (dotted line). 
These three heme adducts display similar MCD spectral patterns, namely relatively 
intense derivative-shaped Soret spectra and mainly positive (450 – 560 nm) and negative 
(560 – 700 nm) features with a prominent trough at 570 – 580 nm. The MCD spectral 
similarity for the ferric-Im complex of sGAF2 and ferric cyt b5, (which contains a bis-
His-ligated heme) suggests identical ligation modes for the two heme proteins. Since bis-
amine- (or bis-His-) and bis-thioether-ligated ferric hemes have been shown to have 
similar MCD spectra 
20
, mono-Im (or His)/mono-thioether-bound ferric heme is expected 
also to share the similarity. In Fig. 3.3D, MCD spectra of ferrous-Im and ferrous-THT 
adduct are compared with the spectrum of ferrous cyt b5. As seen in their ferric state 
(Fig. 3.3C), the MCD spectral patterns of these three ferrous complexes show common 
patterns. In the visible region, extremely intense derivative-shaped features around ~555 
nm are notable. In the Soret region, the MCD spectra of the THT-bound sGAF2 and cyt 
b5 are similar to each other in pattern (except for some intensity difference) while the Im-
complex of sGAF2 shows somewhat different pattern with a noticeably intense trough at 







Figure 3.2 MCD spectra at 4 °C of ferric sGAF2 at pH 7.0 (solid line), ferric sGAF2 at 
pH 10.0 (gray line; reduced by 2.5 times in the 300-440 nm region), ferric horseradish 
peroxidase at pH 7.0 (dashed line), and ferric Mb at pH 7.0 (dotted line) (A) and ferrous 
sGAF2 at pH 7.0 (solid line), ferrous sGAF2 at pH 10.0 (gray line; reduced by 2 times in 
the 460-700 nm region), and ferrous Mb at pH 7.0 (dotted line) (B) are shown. The 
spectra of ferric HRP, ferric Mb, and ferrous Mb are replotted from Ref. 21. Figure 
reprinted with permission from Molitor, B., Stassen, M., Modi, A., El-Mashtoly, S. F., 
Laurich, C., Lubitz, W., Dawson, J. H., Rother, M., and Frankenberg-Dinkel, N. (2013) A 
heme-based redox sensor in the methanogenic archaeon Methanosarcina acetivorans, J. 






Figure 3.3 MCD spectra at 4
o
C of the ferric Im sGAF2 derivative at pH 7.0 (solid line; 
with 2mM Im), the ferric THT sGAF2 derivative at pH 7.0 (dashed line; with 14 mM 
THT), and 50 mM ferric cyt b5 at pH 7.0 (dotted line) (C) and ferrous Im sGAF2 at pH 
7.0 (solid line; with 2 mM Im), ferrous THT sGAF2 derivative in NaPi buffer at pH 7.0 
(dashed line; with 14 mM THT), and ferrous cyt b5 at pH 7.0 (dotted line) (D). The 
spectra of ferric and ferrous cytochrome b5 are replotted from Ref. 22. See the text for 
the types of buffer used for sGAF2, see Ref. 21 for Mb and HRP, and see Ref. 22 for cyt 
b5. Figure reprinted with permission from Molitor, B., Stassen, M., Modi, A., El-
Mashtoly, S. F., Laurich, C., Lubitz, W., Dawson, J. H., Rother, M., and Frankenberg-
Dinkel, N. (2013) A heme-based redox sensor in the methanogenic archaeon 




In addition to MCD, the Dinkel group also used resonance Raman (RR) for heme-
co-ordination determination. In the RR measurements, a six coordinate low spin heme 
was observed, whereas MCD data suggests a high-spin state and a five-coordinate 
structure rather than a six-coordinate structure. The conditions used in the RR 
experiments most likely would not allow detection of a five-coordinate high spin heme 
species. Therefore, a clear assignment of the coordination structure cannot be made, 
suggesting a mixture of different coordination states. When the pH of the buffer was 
changed to pH 10.0, a mixture of a high-spin and low-spin components were also 
detectable in MCD spectra, whereas the differences in UV-vis absorption spectra were 
minor. This low-spin component appears to be arising from a bis-His-type coordination 
structure as judged from the similarity to the Fe(III)-Im complex. Upon reduction of 
MA4561 with dithionite, an Fe(II) complex with a broad Soret band at about 432 nm and 
a visible band at about 557 nm with shoulders at about 528 and 574 nm is formed. An 
additional peak was observed at about 625 nm for the sGAF2 variants. These optical 
absorption properties cannot be clearly assigned to one coordination and spin state but 
again, rather appear like a mixture of different states. With RR data, a mixture of two 
different six coordinate low spin states was observed, and the existence of two species 
was confirmed in the MCD measurements. At pH 10.0, one of the two states becomes 
predominant as judged from the MCD data and is similar to the bis-His-ligated Fe(II) 
form of cyt b5 . The addition of Im or THT for the MCD measurements led to typical six 
coordinate low spin hemes for the Fe(III)-(Im and THT) as well as the Fe(II)-(Im and 
THT) forms.
23, 24
 The Im complexes were hardly distinguishable from the THT 




Similarities of the Im complexes to cyt b5 led to the conclusion that a His/Im or a 
His/THT complex is formed that would resemble a bis-His (cyt b5) or His/Met (many c -
type cytochromes) ligation structure. 
The structural model of sGAF2 generated supports the spectral data with putative 
axial ligands in proximity of the heme cofactor. Specifically, two histidine residues 
(His702 and His704) are located at the proximal side of the heme pocket that might be 
involved in coordinating the heme iron (Fig. 3.4). Initial mutational analyses of these 
residues suggest His702 as the proximal ligand (Nicole Frankenberg-Dinkel, unpublished 
data). In the distal side of the heme two tyrosine (Tyr632 and Tyr665), one methionine 
(Met645), and one histidine (His646) are found. An alternating pair of these groups might 
become axial ligands involved in coordinating to the heme iron depending on the redox 
state. Because ligands like carbon monoxide (CO), THT, and Im are able to bind to the 
heme in MA4561, we envision the distal side of the heme pocket large enough to allow 
THT and Im molecules to enter and coordinate to the heme iron. The above mentioned 
amino acids might also be involved in stabilizing different ligation states of the heme 
without being a direct ligand to the heme iron. Alternatively, they might be exchanged as 
a direct ligand upon binding of external ligands as the above spectroscopic data suggest 
six-coordinate states also in the absence of external ligands. It is interesting to note that a 
cysteine residue (Cys-656) that is speculated to form a covalent bond with the heme is 






Figure 3.4 Structural model of the heme-binding pocket of MA4561, in the second GAF 
domain (aa 608–768) modeled using the PHYRE2 server 
25
, and the modeled structure is 
used to predict putative ligands binding to this structure using 3DLigandSite.
26
 The heme 
cofactor is shown in middle in brown and the protein structure is shown as a green ribbon 
(important amino acids are shown as sticks). Figure reprinted with permission from 
Molitor, B., Stassen, M., Modi, A., El-Mashtoly, S. F., Laurich, C., Lubitz, W., Dawson, 
J. H., Rother, M., and Frankenberg-Dinkel, N. (2013) A heme-based redox sensor in the 




3.3 Part B: Axial Ligand Determination in Z-ISO 
Vitamin A deficiency is a global phenomenon especially in children, causing 
blindness, increased susceptibility to disease, and increased mortality.
27-29
 A sustainable 
approach is to provide provitamin A carotenoids in plant food staples to maintain healthy 
serum levels of vitamin A, a process currently impeded by the lack of detailed 
understanding of the carotegenesis pathway. Dr. Eli Wurtzel’s group (City University of 
New York, NY, USA) discovered the 15-cis-ζ-carotene isomerase (Z-ISO), a novel C=C 
double bond cis-to-trans isomerase.
30
 Z-ISO is essential for provitamin A carotenoid 
biofortification and for plant adaptation to environmental variation, a significant stress 
which affects plant yield. Without Z-ISO, the biosynthetic pathway is blocked.
30
 In-silico 
analysis of this membrane protein led to experimental proof that Z-ISO contains a 
nonheme iron and at least one heme-b. It is hypothesized that isomerization in Z-ISO is 
regulated by oxidation state of the heme b iron with redox-dependent ligand switching 
and a nonheme iron cofactor is indirectly involved. MCD spectroscopy was employed to 
test this working hypothesis. 
3.3.1 Methods: 
Dr. Eli Wurtzel’s group provided us with purified protein samples. MCD spectra 
were measured on a Jasco J815 spectropolarimeter fitted with a Jasco MCD-1B magnet at 
a magnetic field strength of 1.41 T at 4 °C using a 0.5 cm pathlength quartz cuvette. 
Jasco software was used for data acquisition and manipulation as reported previously.
19
 
Concentrations of the heme in Z-ISO samples were determined based on the pyridine 






 Using this method, a value 




ISO at pH 7.4. UV-visible absorption spectra were recorded on a Cary 400 spectrometer, 
before and after each MCD measurement to track sample integrity. Z-ISO protein 
samples were studied in 20 mM Tris buffer containing 20 mM NaCl, 0.2% n-dodecyl-β-
D-maltoside (DDM), 0.1 mM tris(2-carboxyethyl)phosphine (TCEP) and 5% glycerol at 
pH 7.4. The ferrous species of Z-ISO was prepared from ferric protein by flushing a 
rubber septum-sealed cuvette with nitrogen gas for about 10-15 min followed by the 
addition of a small amount of solid sodium dithionite. The CO adducts of the ferrous 
protein were prepared by bubbling the CO gas in to the reduced protein. 
3.3.2 Results and Discussion: 
MCD and UV-vis absorption spectra of ferric state of Z-ISO are shown in Fig. 
3.5, overlaid for comparison with that of a simulated spectra consisting of 50% ferric cyt 
b5 and 50% imidazole (Im)-bound P450-CAM. The spectra (MCD and UV-Vis) of the 
ferric Z-ISO (solid red line in Fig. 3.5) overlaps very well with the simulated spectra 
(dashed blue line in Fig. 3.5) of ferric cyt b5 (bis-His axial ligands) and Im-bound P450-
CAM (His-Cys axial ligand pair). This indicates that the heme(s) in ferric Z-ISO appear 
to have two sets of ligand pairs (His-His and His-Cys) in a ~1:1 ratio, either as a single 
species (with a common His) or as two separate heme centers.  
MCD and UV-vis absorption spectra of the ferrous state of Z-ISO are shown in 
Fig. 3.6, with analogous states of mono imidazole [H93G mono(Im)-Mb] and bis 
imidazole [H93G bis(Im)-Mb] bound H93G-myoglobin mutant are overlaid for 
comparison. The MCD spectral pattern of dithionite-reduced Z-ISO (red solid line in Fig. 
3.6) is similar to that of ferrous H93G bis(Im)-Mb (blue dashed line in Fig. 3.6) which 




coordination in oxidized state to a single His-His coordination in the reduced state. MCD 
and UV-vis absoprtion spectra of the CO-bound ferrous state of Z-ISO are shown in Fig. 
3.7, (calculated for 100% CO saturation, red solid line in Fig 3.7) with those of 
cyclohexylamine-bound H93G myoglobin (H93G-(CHA) Mb) (blue dashed line in Fig 
3.7) and wild type sperm whale myoglobin (Mb) (black dotted line in Fig 3.7) overlaid 
for comparison. The formation of the ferrous-CO complex did not appear to be complete 
even after extensive CO bubbling, judging from the double MCD troughs at ~555 and 
~565 nm. Thus, we have tried to obtain spectra of the CO-saturated form by calculation 
assuming that the observed MCD spectrum was for incompletely CO-saturated ferrous Z-
ISO. The best estimate for CO saturation was 70% CO-bound form in CO-bubbled Z-
ISO. The MCD line shapes and spectral intensities (for main peaks and troughs) are 
roughly similar for the three proteins. MCD spectra of ferric Z-ISO show that the heme 
has two ligand pairs (His-His and His-Cys). This was determined by comparing the Z-
ISO spectrum with that of a simulated mixture of Cyt b5 (bis-His heme coordination) and 
imidazole (Im)-bound P450-CAM (His-Cys heme coordination) (Fig. 3.5). Thus, there 
appear to be two ligand coordination modes in low spin ferric Z-ISO in ~ 1:1 ratio. It 
appears that if there is only one heme center in the protein, His and Cys might occupy the 
distal side of the heme as alternative endogenous ligands while the proximal side is 
ligated by a common His. However if two heme centers exist, there should be two 
separate proximal histidines.  
To help distinguish among the alternate hypotheses, we probed the MCD 
spectrum of the dithionite-reduced Z-ISO. We found that there is a single heme species in 




the heme may be undergoing ligand switching when the protein is reduced. A small 
fraction of high-spin heme b that is His-ligated and five coordinate was also detected, 
which may represent an intermediate. The MCD spectra of CO-bound Fe(II) Z-ISO also 
showed only about 70% CO saturation (Fig. 3.7), suggesting that while the distal His 
ligand is weak, it is not completely replaced by exogenous ligand. 
Based on these data, a working hypothesis is proposed that an inactive Z-ISO 
carries an oxidized heme Fe(III), where cysteine blocks substrate access to the iron in the 
active site. Reduction of the heme switches coordination of the heme to bis-His, thus 
exposing the active site for substrate access to the heme Fe(II). A schematic 
representation of the heme ligand switching is summarized in below Scheme 3.1. 
 
 

























Figure 3.5 MCD and UV-vis absorption spectra at 4 °C of ferric Z-ISO at pH 7.0 (solid 
red line), overlaid with simulated spectra consisting of 50% ferric cyt b5 and 50% ferric 
Im-bound P450-CAM (blue dashed line). The simulated spectra are replotted from 
individual spectra in Refs. 22 and 32 respectively 
.
Wavelength (nm)



































































Figure 3.6 MCD and UV-vis absorption spectra at 4 °C of ferrous Z-ISO at pH 7.0 (solid 
red line), with H93G mono(Im)-Mb (green solid line) and H93G bis(Im)-Mb (blue 
























































Figure 3.7 MCD and UV-vis absorption spectra at 4 °C of CO-bound ferrous Z-ISO 
calculated for 100% saturation at pH 7.0 (solid red line), with H93G-(cyclohexylamine) 
Mb (blue dashed line) and wild type (WT) Mb (black dotted line). The spectra of ferrous-
CO H93G-(cyclohexylamine) Mb (UV-Vis data: Dawson, J. H., Kadkhodayan, S., 
Zhuang, C., Sono, M., unpublished data), and WT Mb spectra are replotted from Refs. 33 
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3.4 Part C: Demonstration of Oxy-ferrous Heme Adduct Formation in 
Ruthenium-diimine Photosensitizer Modified P450-BM3 
Cytochrome P450 enzymes are capable of hydroxylating unactivated C-H bonds 
with the help of molecular dioxygen and reducing equivalents at ambient temperature and 
physiological pH with a high catalytic efficiency. This synthetic ability makes them 
particularly attractive for biotechnological applications; however complete dependence of 
the reactions on NAD(P)H and the reductase domain for electron transfer impedes their 
use as bio-catalysts. Amongst the numerous attempts to circumvent this issue, Dr. Lionel 
Cheruzel’s lab (San Jose State University, San Jose, CA) has developed a series of hybrid 
enzymes using P450-BM3 (CYP102) and photosensitizer that could be activated using 
light. These hybrid enzymes consists of Ru(II)-diimine photosensitizer, covalently 
attached to non-native single cysteine residue close to the P450 BM3 heme domain.
35
 
Photoactivation converts the Ru(II) into a highly reductive Ru(I) species which provides 
the two necessary electrons to the heme domain in successive one-electron transfer 
steps.
36
 Introduction of these mutations and/or covalent attachment of the Ru(II) 
photosensitizer does not significantly alter the binding of lauric or palmitic acid. 
Particularly the Ru(bpy)2phenA (bpy= bipyridine and phenA= 5-acetamido-1,10 
phenanthroline) modified L407C mutant of P450-BM3 was found to have a high turnover 
number in the hydroxylation of lauric acid. In order to ascertain the ability of the hybrid 
enzyme to form the oxy-ferrous intermediate, Dr. Cheruzel’s lab collaborated with our 
lab to use MCD spectroscopy to examine the integrity of the oxyferrous intermediate. 
3.4.1 Methods: 




and L407C-Ru-diimine hybrid sample prepared as described in 
37
. MCD spectra were 
measured on a Jasco J815 spectropolarimeter fitted with a Jasco MCD-1B magnet at a 
magnetic field strength of 1.41 T at 4 °C and -50 °C in a mixed solvent (see below) using 
a 0.5-cm-path length quartz cuvette. Jasco software was used for data acquisition and 
manipulation as reported previously.
19
 Concentrations of the P450-BM3 L407C-Ru-





ferric protein. UV-vis absorption spectra were recorded on a Cary 400 spectrometer, 
before and after each MCD measurement to track sample integrity. Sample preparation 
and data collection was done as previously described in Ref. 
38
, and in complete detail in 
39
. The L407C-Ru-diimine hybrid sample was analyzed in a buffer comprising of 0.3 M 
Tris at pH 8.0 and glycerol in a starting ratio of 30/70 (v/v), with the final concentration 
of glycerol in the protein sample being ~60% (after some dilution with dithionite aqueous 
solution). Before adding sodium dithionite, the sample was degassed over 3 h on ice with 
a slow stream of nitrogen gas in a rubber septum-sealed cuvette to ensure complete and 
highly anaerobic condition.  
3.4.2 Results and Discussion: 
We examined the oxy complex of P450-BM3 L407C-Ru-diimine hybrid sample 
in cryo-solvent in both the presence and absence of substrates. The oxy complex of the 
Ru-diimine labeled protein was made by bubbling O2 in the reduced protein (dissolved in 




The P450-BM3 L407C-Ru-diimine hybrid (solid red 
line in Fig. 3.8) forms a stable oxy-complex at -50
o 
C whose MCD and UV-Vis 
absorption spectra are very similar to the O2 adduct of wild-type P450 BM3 (blue dashed 




The O2-bound Ru-diimine labeled as well as WT P450-BM3 may be stable even at 
slightly higher temperatures (such as -30
o 
C), but we have not examined the temperature 
dependence of its stability in this work. MCD and UV-vis absorption spectra of lauric 
acid (LA) and palmitic acid (PA)-bound P450-BM3 L407C-Ru-diimine hybrid (pink 
solid line and green solid line in Fig. 3.9) show that they form a stable oxy-complex just 
like the Ru-diimine labeled protein (red dotted line in Fig. 3.9) at -50
o
C. Their MCD and 
UV-Vis absorption spectra are very similar to those of the O2 adduct of the substrate-free 
enzyme, as seen in Fig. 3.9. With LA and PA substrates, we did not observe a marked 
conversion from low-spin species to high-spin species on substrate addition in the ferric 
protein in 60-70% glycerol buffer as is seen in aqueous buffer. We initially thought this 
was resulting from incomplete binding of the substrate although similar results have been 
reported earlier by Dawson and co-workers.
38
 Thus we set out to test another substrate N-
palmitoylglycine (NPG) that has been shown to bind P450-BM3 with a low Kd value.
40
 
We observed that conversion to a high-spin form spectrum upon substrate binding to 
ferric enzyme (low spin) is not pronounced in the 70:30 Glycerol/Tris buffer (pH 8). 
However, nearly complete conversion to a high-spin state can be clearly seen in the 50 
mM Tris, pH 7.2 buffer (without glycerol) at room temperature (~22
 o
C) (blue dashed 
line in Fig. 3.10). Analogous P450-CAM spectra with and without the substrate camphor 
are overlaid for comparison in Fig. 3.10. Just like the other substrate containing samples, 
the oxy complex of the Ru-diimine labeled protein was made by bubbling O2 in the 
reduced protein in ~65% glycerol solution (the initial 70/30 Glycerol/0.3M Tris buffer, 







Figure 3.8 MCD and UV-Vis absorption spectra of the O2 adduct of the P450-BM3 
L407C-Ru hybrid (blue dashed line), wild-type P450 BM3 (blue dashed line) as well as 
bacterial wild-type P450CAM (black dotted line) recorded at -50
o
C in ~60% glycerol 
containing 0.3 M Tris buffer at pH 8.0. The spectra of ferrous di-oxy P450CAM are 
replotted from Ref. 41 
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Figure 3.9 MCD and UV-Vis absorption spectra of the O2 adduct of the substrate-free 
P450-BM3 L407C-Ru hybrid (red dotted line), LA-bound form (pink solid line) as well 
as PA-bound form (green solid line) recorded at -50
o
C in ~60% glycerol containing 0.3 
M Tris buffer at pH 8.0  
Wavelength (nm)
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Figure 3.10 MCD and UV-Vis absorption spectra of the ferric substrate-free P450-BM3 
L407C-Ru hybrid (red solid line), ferric NPG-bound form (blue dashed line) as well as 
ferric substrate-free P450-CAM form (black dotted line) and ferric camphor-bound P450-
CAM (pink dashed line) recorded in aqueous buffer. The spectra of ferric substrate-free 
P450-CAM and ferric camphor-bound P450-CAM MCD are replotted from Ref. 42 
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Figure 3.11 MCD and UV-Vis absorption spectra of the O2 adduct of the substrate-free 
P450-BM3 L407C-Ru hybrid (red solid line), NPG-bound form (blue dashed line) as well 
as camphor-bound P450-CAM (black dotted line) recorded at -50
o
C in ~60% glycerol 
containing 0.3 M Tris buffer at pH 8.0. The spectra of oxy-ferrous camphor-bound 
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 While the NPG-bound protein forms a comparable oxy-complex just 
like the substrate-free Ru-diimine-labeled protein at -50 
o
C, as seen in Fig. 3.11 the oxy-
P450BM3-Ru + NPG complex appeared to be less stable than the oxy-complex without 
substrate or with LA or PA even at –50 
o
C. This was judged from the gradual MCD 
spectral changes (to the ferric state) upon O2 bubbling into the deoxyferrous form at –50 
o
C compared with little spectral changes during the same treatments and time periods for 
substrate-free and LA- or PA-bound P450BM3-Ru-diimine proteins. In fact, the Soret 
MCD peak and trough intensities for the NPG-bound oxy-P450BM3-Ru are somewhat 
higher than the other samples, which is a sign of ferric form contamination. 
3.5 Part D: Heme Axial Ligand Determination in Phu_R 
The Phu_R is a TonB dependent outer membrane receptor that is part of the 
Pseudomonas heme uptake system from Pseudomonas aeruginosa.
43
 Phu_R helps in the 
transport of heme to the periplasm from where a further cascade helps in retrieval of iron 
(an essential micronutrient for survival and virulence of bacterial pathogens) from the 
heme.
44, 45
 Sequence alignments of TonB dependent outer membrane receptors have 
shown that heme is coordinated through two histidine residues, however, a conserved 
histidine observed on the extracellular FRAP loop of other receptors is missing in Phu_R. 
There are other potential ligands present in the vicinity, specifically His-102, Tyr-519, 
Tyr-529 and His-530. To confirm the correct identity of the heme coordinating ligands 
Dr. Angela Wilks (University of Maryland, Baltimore, MD) collaborated with our lab to 
conduct MCD experiments on the WT and mutant enzymes. 
3.5.1 Methods: 




proteins Y529A, Y529H and H102A (data unpublished). MCD spectra were measured on 
a Jasco J815 spectropolarimeter fitted with a Jasco MCD-1B magnet at a magnetic field 
strength of 1.41 T at 4 °C using a 0.2 cm pathlength quartz cuvette. Jasco software was 
used for data acquisition and manipulation as reported previously.
19
 Concentrations of the 
samples were tentatively determined (based on the pyridine hemochromogen method) for 




), Y529A Phu_R 









UV-vis absorption spectra were recorded on a Cary 400 spectrometer, before and after 
each MCD measurement to track sample integrity. Phu_R protein samples were studied 
in 50 mM Tris pH 7.5, 50 mM NaCl, and 0.06% (w/v) lauryldimethylamine-oxide 
(LDAO) at pH 7.5. The imidazole (Im) and cyanide (CN¯) adducts were prepared by 
adding aliquots of Im and KCN stock solutions (1 M or diluted concentrations, pH 
adjusted to ~7) to the protein, respectively, until apparent saturation (no further spectral 
change) was reached. The ferrous species of Phu_R prepared from the ferric protein in 
the presence of exogenous ligands, by flushing a rubber septum-sealed cuvette with 
nitrogen gas for about 10-15 min followed by the addition of a small amount of solid 
sodium dithionite was found to denature the sample. Thus, for the purpose of this study 
we only looked at ferric forms of the protein. 
3.5.2 Results and Discussion: 
We have examined the Phu-R protein (enzyme) along with its mutants, with 
magnetic circular dichroism (MCD) and UV-visible (UV-Vis) absorption spectroscopy in 
its ferric [Fe(III)], ferric + cyanide [Fe(III)-CN] and ferric + imidazole [Fe(III)-Im] bound 




corresponding states of legehemeglobin-A + phenol, cytochrome b5 (bis-His-ligated 
heme protein), mono-4-methylimidazole (4-MeIm)-bound H93G Mb (proximal cavity 
Mb mutant), bis-His bound H93G Mb, and wild type myoglobin (WT-Mb), for 
comparison. The MCD spectral pattern of ferric WT PhuR as seen in Fig 3.12 (red solid 
line) is somewhat similar in both the Soret (350 - 450 nm) and visible regions (450 - 700 
nm) to that of phenol-bound ferric leghemoglobin a (Lb-a) (black dashed line in Fig. 
3.12) which has a proximal His and distal phenol (Tyr equivalent) heme ligation. This 
strongly suggests that ferric WT PhuR has His-Tyr type of heme ligation. Judging from 
the slightly larger MCD trough intensities at ~570 and ~420 nm, Fe(III) WT PhuR 
appears to contain more low-spin component than phenol-bound Lb-a. When the MCD 
and UV-vis absorption spectra of Fe(III) WT PhuR was titrated with cyanide as seen in 
Fig. 3.13, a spectral shift of 6 nm was observed on apparently saturation (Kdapp ~ 39.7 
μM). However, the incomplete conversion of the ferric heme to low-spin (remaining 
absorption peak at ~620 nm and MCD trough at ~630 nm) indicates that the heme is not 
totally converted to a cyanide complex (100% low-spin species).  
The MCD and UV-Vis absorption spectral patterns of ferric Y529A PhuR as seen 
in Fig. 3.14 shows the presence of charge-transfer UV-Vis spectral bands at ~610 and 
~490 nm, an MCD trough at ~630 nm and relatively small MCD peak to trough intensity 
in the Soret region. This indicates that ferric Y529A PhuR protein (red solid line in Fig. 
3.14) heme is high-spin; however, its MCD/UV-Vis absorption spectra do not resemble 
those of meta-aqua Mb (black dotted line in Fig. 3.14) or mono-4-methylimidazole-







Figure 3.12 MCD and UV-vis absorption spectra of ferric WT PhuR (red solid line) 
overlaid for comparison with phenol-bound ferric Lb-A (black dashed line). The Lb-A 
spectra are replotted from Ref. 46 
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Figure 3.13 MCD and UV-vis absorption spectra of ferric WT PhuR (red solid line) 
overlaid for comparison with CN-bound ferric WT Phu_R (blue dashed line). 
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Figure 3.14 MCD and UV-vis absorption spectra of ferric Y529A PhuR protein (red 
solid line) overlaid for comparison with that of meta-aqua Mb (black dotted line) 
replotted from Ref. 21 (UV-Vis data: Dawson, J. H., Kadkhodayan, S., Zhuang, C., Sono, 
M., unpublished data) and mono-4-methylimidazole-bound H93G Mb (blue dashed line) 
replotted from Ref. 47.  
Wavelength (nm)
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Figure 3.15 MCD and UV-vis absorption spectra of ferric Y529A Phu_R protein (red 
solid line) overlaid for comparison with and Im- adducts of ferric Y529A Phu_R (black 
dotted line) and (blue solid line), respectively.  
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Fe(III) Y497A in Tris-NaCl Buffer pH 7.5 














Figure 3.16 MCD and UV-vis absorption spectra of ferric Y529H PhuR protein (green 
solid line) overlaid for comparison with ferric cyt b5 (red dashed line) replotted from Ref 
22 and bis-imidazole bound H93G Mb (black dotted line) replotted from Ref. 33 
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In addition, a noticeable MCD shoulder at ~380 nm is observed for the Fe(III) 
Y529A PhuR. KCN and Im titrations of ferric PhuR Y529A as seen in Fig. 3.15 resulted 
in formation of the respective ligand complexes of this mutant exhibiting Soret 
absorption peak shifts from 407 nm to 411 nm (Im) and 418 nm (CN-) and appearance of 
low-spin type visible region absorption peaks at ~533 nm (Im) and ~540 nm (CN-). Soret 
MCD peak-to-trough intensities also increase by more than two-fold for both ligands as a 
sign of formation of low-spin complexes. However, similar to the case of WT Fe(III) 
PhuR (Fig. 3.13), the high-spin charge-transfer band at ~610 nm does not disappear 
completely as well as the remaining MCD trough at ~630 nm for the both ligands. Thus, 
ligand complex formation seems to be incomplete, especially for the cyanide adduct that 
should be totally low-spin. 
The MCD spectral pattern of ferric Y529H PhuR as seen in Fig 3.16 (green solid 
line) overlaps essentially perfectly in both the Soret (350 – 450 nm) and visible regions 
(450 – 700 nm) to that of ferric cyt b5 (red dashed line) and bis-imidazole bound H93G 
Mb (black dotted line), both of which have bis-His (Im) heme ligation, clearly suggesting 
that Y529 to H mutation imparts a bis-His ligation to the heme. 
3.6 Conclusion: 
We have analyzed the sGAF2, Z-ISO, P450-BM3 L407C-Ru hybrid sample and 
Phu_R heme proteins with MCD and compared their spectra against data from the heme 
protein spectral library recorded and maintained by our lab. In the case of sGAF2, Z-ISO 
and Phu_R proteins, MCD helped in identification of the heme coordinating ligands, 
whereas in the case of P450-BM3 L407C-Ru-diimine hybrid, MCD was used to 




been used to hypothesize a working mechanism for the Z-ISO enzyme. For the P450-
BM3 L407C-Ru-diimine hybrid, the MCD characterization of the ferrous dioxygen 
intermediate was used to ascertain that the engineered enzyme was following a normal 
P450 turnover pathway. The fingerprinting ability of MCD coupled with other 
spectroscopic techniques such as resonance Raman and EPR makes it a valuable tool in 
investigating the structure and function of novel heme enzymes. 
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